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Abstract 
The likelihood of O-GlcNAc glycosylation in human proteins is predicted using the ridge 
regression estimated linear probability model (LPM). To achieve this, sequences from three similar 
post-translational modifications (PTMs) of proteins occurring at, or very near, the S/T-site are 
analyzed: N-glycosylation, O-mucin type (O-GalNAc) glycosylation, and phosphorylation. Results 
found include: 1) The consensus composite sequon for O-glycosylation is: ~ (W–S/T–W), where 
“~” denotes the “not” operator. Thus, ~W – S/T – W, W – S/T – ~W, or ~W – S/T – ~W are necessary 
for O-glycosylation. 2) The consensus sequon for phosphorylation is ~ (W–S/T/Y/H–W); although 
W–S/T/Y/H–W is not an absolute inhibitor of phosphorylation. 3) For LPM estimation, N-
glycosylated sequences are found to be good approximations to non-O-glycosylatable sequences; 
although N – ~P – S/T is not an absolute inhibitor of O-glycosylation. 4) The selective positioning 
of an amino acid along the sequence, differentiates the PTMs of proteins. 5) Some N-glycosylated 
sequences are also phosphorylated at the S/T-site in the N – ~P – S/T sequon. 6) ASA values for N-
glycosylated sequences are stochastically larger than those for O-GlcNAc glycosylated sequences. 
7) Structural attributes (beta turn II, II´, helix, beta bridges, beta hairpin, and the phi angle) are 
significant LPM predictors of O-GlcNAc glycosylation. The LPM with sequence and structural 
data as explanatory variables yields a Kolmogorov-Smirnov (KS) statistic value of 99%. 8) With 
only sequence data, the KS statistic erodes to 80%, underscoring the germaneness of structural 
information, which is sparse on O-glycosylated sequences. With 50% as the cutoff probability for 
predicting O-GlcNAc glycosylation, this LPM mispredicts 21% of out-of-sample O-GlcNAc 
glycosylated sequences as not being glycosylated. The 95% confidence interval around this 
mispredictions rate is 16% to 26%.   
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Introduction  
The process of post-translational modification (PTM) of proteins has allowed cells to vastly 
increase the otherwise normal array of functions that proteins carry out. PTMs are essential 
modifications that occur in higher eukaryotes. Glycosylation is one type of modification 
that chemically alters proteins by the enzymatic or non-enzymatic addition of glycans. 
There are two main types of glycosylation present: N-linked and O-linked [1]. There are 
two types of O-linked glycosylation in cells: mucin-type O-linked glycosylation (O-
GalNAc); and several types of non-mucin O-glycans, which include α-linked O-fucose, β-
linked O-xylose, α-linked O-mannose, β-linked O-GlcNAc (N-Acetyl Glucosamine), α- or 
β-linked O-galactose, α- or β-linked O-glucose glycans, and O-GlcNAcylation (or O-
GlcNAc). In addition, C-linked, S-linked and non-enzymatic glycation processes exist [2]. 
The consensus sequon for N-linked glycosylation is N – X – S/T, where X is not proline. 
Two consensus sequons for C-linked glycosylation are: W – X – X – W and W – S/T – X – 
C [3]. No consensus sequon for O-glycosylation is known thus far.  
 
O-GlcNAc modification is the attachment of β-N-Acetyl Glucosamine (GlcNAc) to protein 
serine (S) or threonine (T) amino acid residues via the O-linked glycosylation process [4]. 
O-GlcNAcylation occurs primarily in nucleocytoplasmic proteins [5, 6]. O-GlcNAcylation 
mechanism targets numerous transcription factors, tumor suppressors, kinases, 
phosphatases, and histone-modifying proteins [6-9]. Furthermore, the monoaddition of 
GlcNAc is suggested to be the most significant glycosylation process in the regulation of 
metazoan cytosolic and nuclear proteins [10, 11]. Often, the S/T residues, which are 
targeted by O-GlcNAcylation, are also targets of kinases and phosphatases. Hence, the 
consensus sequon for O-linked glycosylation can also be the one for phosphorylation. 
These residues are both dynamic and inducing in nature [12]. Thus, to summarize, O-
GlcNAcylation plays a major role in modulating kinase-induced signal transduction 
pathways [13], supporting the notion that O-GlcNAcylation has an important biological 
role. 
 
The source of GlcNAc for O-GlcNAcylation in eukaryotic cells is UDP-N-Acetyl 
Glucosamine [14], UDP-GlcNAc, obtained from glucose in the hexosamine biosynthetic 
pathway (HBP). The attachment process of O-GlcNAcylation is catalyzed via O-linked β-
N-Acetyl Glucosamine transferase [15, 16] or O-GlcNAc transferase and is removed by O-
linked β-N-acetyl- glucosaminidase or O-GlcNAcase [16]. Currently, O-GlcNAc 
transferase is the only known enzyme in mammals responsible for this addition of GlcNAc 
[17]. O-GlcNAc transferase is found in the nucleus, mitochondria, and cytoplasm of cells. 
  
O-GlcNAc transferase has important roles in many biological processes and diseases. 
These include type 2 diabetes and its complications, such as blindness, renal failure, and 
nerve damage; diabetes-accelerated atherosclerosis; dyslipidemia; cardiovascular diseases; 
aging and cancer [18-23]. Additionally, O-GlcNAc transferase is associated with 
tauopathies, including Alzheimer’s disease, dementia, and Parkinson’s disease [24, 25]. 
Recently, the role of glycosylation in neuroblastoma has taken center stage [26]. 
  
The common underlying cause of such diseases is due to the over- or under- active process 
of O-GlcNAcylation. With the complex metabolic processes in O-GlcNAcylation and its 
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critical role in the regulation of cellular processes, it is not unusual to consider abnormal 
O-GlcNAcylation activity as contributing to various diseased states. This concept suggests 
that an in-depth understanding of sequence and structural parameters that drive O-
GlcNAcylation may shed some light on O-linked glycosylation.  
 
The goal of this paper is to use the ridge regression (RR) estimated linear probability model 
(LPM) to predict the likelihood of O-GlcNAc glycosylation in human proteins [27-33]. A 
detailed description of the statistical methodology used herein is in a predecessor paper 
[34]. The LPM models a binary outcome: O-GlcNAc glycosylated or not. So, the LPM 
estimation dataset requires two data subsets: O-GlcNAc glycosylated sequences and 
sequences that cannot be O-GlcNAc glycosylated. Experimentally one can determine if a 
protein is O-glycosylated. Thus, getting data on O-glycosylated proteins is straightforward. 
Getting data on proteins that are highly unlikely (or impossible) to be O-glycosylated is 
quite challenging, because a consensus sequon for O-glycosylation is needed. To 
understand whether a true, or even approximate, consensus sequon for O-glycosylation 
exists, a family of similar sequences with PTMs of proteins occurring at the S/T-site is 
collected. This family includes sequences on the following PTMs of proteins: N-
glycosylation, O-GalNAc glycosylation, and phosphorylation. The rest of this paper 
documents the analyses done with all of this collected data.  
Materials and Methods 
Data Collection 
a. Data collected on the glycosylated sequences used for analysis herein is stored in an 
Excel spreadsheet: glycos_public.xlsx (which is available upon request). This data, and 
key operations performed on it, are described in Table 1. Data is collected from two 
resources (dbOGAP [35] and PhosphoSitePlus [36]) as described in Table 1. 
 
b. Structural data is obtained from the Protein Data Bank (PDB) [37], and the PDB-ID 
codes used are provided in glycos_public.xlsx in the column labeled PDBID. In 
dbOGAP, the total number of UniProt sequences is 376; and, of these, 39 have 
structural information. Several unique structures exist for each of the 39 sequences. 
This results in the 39 sequences having a total of 998 structures with unique PDB-IDs. 
Each structure is unique in terms of different ligands/drugs bound to them. Although 
there is redundancy in this data from a sequence standpoint, these 39 sequences have 
different structural attributes as defined by phi-psi angles and ASA, which are 
important structural variables. In order to make sure that these are real structural 
differences, similar structures were superposed to calculate a RMSD (root-mean-
squared-deviation). It is confirmed that the resolution of the structures is high enough 
to believe in the subtle conformational changes captured in the data. The 10 residues to 
the left of the S/T-site, and the 10 residues to the right of the S/T-site, are superposed to 
see if the S/T-site displays slightly different conformations. An example is presented in 
Figure 1. This example supports the rationale behind using all of the redundant 
sequences for regression model building. It is not surprising that the S-site, in this 
example, is flexible enough to accommodate its role in a multitude of cellular 
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processes. Residues that have maximum deviation (0.5-1.0Å) are close to the S-site. 
Residues farther out superimpose with less than 0.1Å RMSD. 
 
Figure 1: Superposition of ±10 positions around the S-site in protein structures.  
In this example, the PDB-IDs are: 1AZM, 1BZM, 1CRM, 1CZM, 1HCB, 1HUG, 1HUH, 
1J9W, 1JV0, 2CAB, and 2FOY. The figure was generated using PyMOL software. The  
Serine residue is colored in yellow. 
 
 
c. The sequence and taxonomy information for the data used in the analysis are extracted 
from the UniProtKB database (www.uniprot.org) and shown in columns labeled 
Uniprot_Accession_No and Protein_Organism in glycos_public.xlsx [38]. The ligand 
information (see column labeled Ligand_Sequence in glycos_public.xlsx) is obtained 
from the PDBsum database [39]  
 
d. Accessible Surface Area (ASA) values (see column labeled ASA in glycos_public.xlsx) 
are obtained using the ASAView tool and database [40]. The definitions in the 
ASAView tool are used to classify the amino acids into five categories: positively 
charged residues (R, K, H), negatively charged residues (D, E), polar uncharged 
residues (G, N, Y, Q, S, T, W), Cysteine (C), and hydrophobic residues (L, V, I, A, F, 
M, P). 
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Table 1: Description of the collected data* 
Dataset 
name 
given 
Data description 
Identified in 
glycos_public.xlsx 
by 
Sample Size Source 
dbogap-
str 
O-GlcNAc glycosylated 
sequences with sequence and 
structural data 
Oglycos_status = yes 
1,105. Where 998 are human with 
unique PDB-IDs; of these, only 16 are 
inferred from known O-GlcNAcylated 
orthologs (the others are experimentally 
validated). The remaining 107 
sequences are non-human. These 998 
sequences are in-sample data for the 
proteins with sequence and structural 
information. The structural information 
on the 998 sequences was collected 
dbOGAP 
dbogap Human O-GlcNAc glycosylated sequences  Ogly_only_seq = yes 
376. These are unique UniProt 
Accession No. and position pairs.  dbOGAP 
dbogap-
unique-
seq-with-
str 
Extract of human sequences 
from dbogap-str with unique 
UniProt Accession number 
and position pairs (i.e., 
structure is ignored) 
Not identified as it is 
derivable using 
software like SAS or 
R 
39. Of these, 28 are experimentally 
validated and the remaining 11 are 
inferred. These 39 sequences become 
998 in dbogap-str via the richness in 
conformational changes associated with 
them. Of the 39 sequences, 25 are 
unique proteins (UniProt Accession 
Nos.) 
N/A 
dbogap-
seq 
Merge dbogap with dbogap-
unique-seq-with-str, by 
UniProt Accession No. and 
position, and retain those in 
the first dataset, but not in the 
second. 
Not identified as it is 
derivable 340 N/A 
Oglc-
PS+ 
Additional extract of O-
GlcNAc glycosylated human 
sequences Ogly_21 = yes 
411. Of these, 59.12% are glycosylated 
at S and the others at T. Of the 25 
unique human proteins in dbogap-
unique-seq-with-str, 18 are in Oglc-
PS+ 
PhosphoSitePlus 
Oglc-
non-
dbogap 
Merge Oglc-PS+ with 
dbogap-seq and dbogap-
unique-seq-with-str, by 
UniProt Accession No. and 
position, and retain those in 
Oglc-PS+, but not in dbogap-
seq or dbogap-unique-seq-
with-str 
GLCNAC_s1 = yes 
259. This is used as out-of-sample data. 
Note, 152 of the 340 sequences in 
dbogap-seq are in Oglc-PS+. The total 
number of unique sequences (UniProt 
Accession No. and UniProt position 
pairs) in dbogap and Oglc-PS+ is 638. 
N/A 
Ogal 
O-GalNAc glycosylated 
human sequences GALNAC_s1 = yes 
2,079. This is used as out-of-sample 
data. Of these, 60.27% are glycosylated 
at T and the others at S 
PhosphoSitePlus 
Ngly N-glycosylated sequences glyco_status = yes 
6,328. Of these, 2,422 are “Homo 
sapiens (Human)”. Of the 2,422, the 
count of sequences with more than one 
sugar bound is 1,083. These 1,083 
sequences are in-sample data for the 
proteins with sequence and structural 
information. If structure is ignored, 
there are 361 unique sequences (i.e., 
unique UniProt Accession No. and 
position pairs). These 361 sequences 
are in-sample data for the proteins with 
only sequence data 
Gana et al.[34] 
Phosy 
 
[41]Phosphorylated 
sequences 
Not identified. This 
is archived in a 
separate file: 
Phosy.csv 
363,256. Of these, 227,810 are human 
with amino acids in ±7 positions of the 
S/T-site; and 58.95%, 24.51%, and 
16.54% are phosphorylated at S, T and 
Y, respectively 
PhosphoSitePlus 
WSTW-
Uniprot 
Human sequences with the 
W– S/T–W sequon wstw = yes 
236. This extract is unique in terms of 
Uniprot Accession No. & position pairs UniProt 
* The columns describe the dataset name, counts of the sequences collected, description of the data and its source. For example, 1,105 O-
GlcNAc glycosylated proteins with sequence and structural data are collected and stored as dataset dbogap-str. This data is identified in 
glycos_public.xlsx by “yes” in column Oglycos_status. In terms of unique PDB-IDs, there are 998 sequences in this data. The last column cites 
the source of the collected data, dbOGAP.
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e. The ProMotif database is used to obtain the turn types: http://www.ebi.ac.uk/thornton-
srv/databases/cgi in/pdbsum/GetPage.pl?pdbcode=n/a&template=doc_promotif.html. 
These are in glycos_public.xlsx in the column labeled Turn_Type.  
 
 
Results from examining the empirical data 
The distribution of groups of residues around the O-GlcNAc glycosylated proteins, in 
dataset dbogap-seq, is shown in Table 2. It is striking that the immediate vicinity of the 
S/T-site is predominantly polar uncharged and hydrophobic at position –1 and +1, 
respectively.  
 
The marginal distributions of residues in the vicinity of the O-GlcNAc and O-GalNAc 
glycosylated sequences are shown in Table 3 and Table 4, respectively. About 10% or more 
of the sequences in positions –4 thru –8 have S, P, or A in Table 3; positions –2 and –3 are 
proline rich; and amino acids C, F, M, and W do not occur much. There are some 
differences between amino acid preferences in O-GlcNAc and O-GalNAc glycosylated 
sequences. As reported by earlier studies, the vicinity of the S/T-site in O-GalNAc 
glycosylated sequences is proline rich.  
 
The marginal distributions of residues in phosphorylated sequences are shown in Table 5. 
Along the sequence, S tends to show up the most in phosphorylated sequences. There are 
higher percentages of charged amino acids in these sequences, as well. 
 
Table 2: Percentage distribution of amino acids grouped according to their physiochemical properties around 
the O-GlcNAc glycosylated S/T-site in the data 
Amino Acid 
Position 
Positively 
charged 
Negatively 
charged 
Polar 
uncharged Cystein Hydrophobic 
–8 14.71 8.53 40.88 0.59 35.29 
–7 13.82 8.82 36.47 1.47 39.41 
–6 14.12 7.94 42.35 0.59 35.00 
–5 18.53 8.82 32.35 0.59 39.71 
–4 18.82 8.24 35.59 0 37.35 
–3 10.88 5.00 30.00 0.88 53.24 
–2 14.12 4.41 28.82 0.29 52.35 
–1 8.24 3.82 38.24 0.59 49.12 
0 (S/T-site)  
+1 10.59 8.24 52.35 0.29 28.53 
+2 6.47 6.47 45.29 0.29 41.47 
+3 8.82 4.71 44.71 0.59 41.18 
+4 10.88 6.18 48.24 0 34.71 
+5 16.47 5.00 32.35 0.59 45.59 
+6 16.47 6.18 37.06 0.29 40.00 
+7 15.88 6.76 44.41 0.29 32.65 
+8 14.41 6.47 42.94 0.59 35.59 
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Table 3: Marginal distributions (%) of amino acids by position relative to the S/T-site 
Amino  
Acid 
Eight positions to the left/right of the S/T-site for O-GlcNAc glycosylated sequences 
 -8 -7 -6 -5 -4 -3 -2 -1 +1 +2 +3 +4 +5 +6 +7 +8 
A 9.1 12.7 7.1 12.1 11.5 8.8 11.8 10.3 9.1 17.4 12.1 8.5 10.3 10.6 7.4 7.1 
C 0.6 1.5 0.6 0.6 0 0.9 0.3 0.6 0.3 0.3 0.6 0 0.6 0.3 0.3 0.6 
D 4.4 2.7 2.7 3.8 4.1 1.5 2.4 2.7 2.9 3.5 2.1 2.4 3.2 2.4 3.8 2.4 
E 4.1 6.2 5.3 5.0 4.1 3.5 2.1 1.2 5.3 2.9 2.7 3.8 1.8 3.8 2.9 4.1 
F 1.5 1.8 2.9 1.5 2.4 2.4 1.8 1.8 2.4 1.2 1.8 1.5 2.7 2.4 1.2 1.8 
G 8.5 6.2 5.9 5.9 5.3 6.8 6.8 5.6 9.4 8.5 7.1 9.1 5.6 6.5 8.8 5.9 
H 3.2 0.9 2.1 0.6 3.5 2.7 1.8 1.5 1.5 2.7 1.5 1.2 2.1 3.2 1.5 3.2 
I 4.4 4.7 3.2 4.1 3.5 4.4 2.9 4.4 2.9 2.1 3.5 3.2 5.9 3.8 1.8 2.9 
K 7.1 6.5 5.3 8.2 7.1 3.8 7.1 3.8 4.4 1.2 2.4 5.0 7.4 5.9 7.4 5.9 
L 7.4 5.6 6.5 10.0 5.9 5.6 7.1 5.0 5.6 4.1 7.7 5.3 7.7 6.2 5.9 6.8 
M 1.2 1.5 1.8 1.5 2.1 0.3 1.2 0.9 0.6 1.2 0.3 1.8 2.4 0.9 1.5 1.2 
N 2.9 1.8 3.5 0.9 1.5 2.1 1.8 0.3 1.5 2.1 3.8 1.8 1.2 2.1 1.8 2.4 
P 6.2 8.2 8.5 6.5 7.7 17.9 19.4 6.8 2.7 8.8 9.1 6.5 7.9 11.8 7.7 8.8 
Q 4.7 2.4 5.6 3.2 4.7 2.7 5.6 2.7 9.1 5.6 7.9 2.7 3.8 5.6 6.2 6.2 
R 4.4 6.5 6.8 9.7 8.2 4.4 5.3 2.9 4.7 2.7 5.0 4.7 7.1 7.4 7.1 5.3 
S 14.4 13.2 14.7 10.0 12.9 6.8 8.8 12.1 16.5 19.4 14.7 19.1 8.5 11.8 13.2 15.0 
T 6.8 8.8 9.7 8.8 8.2 8.5 4.7 13.8 13.8 8.8 8.8 13.5 10.0 7.1 11.8 10.0 
V 5.6 5.0 5.0 4.1 4.4 13.8 8.2 20.0 5.3 6.8 6.8 7.9 8.8 4.4 7.4 7.1 
W 0.6 0.9 1.2 0.3 0.3 0.3 0 0 0 0 0.3 0 0 0 0.9 0.6 
Y 2.9 3.2 1.8 3.2 2.7 2.9 1.2 3.8 2.1 0.9 2.1 2.1 3.2 4.1 1.8 2.9 
 
Table 4: Marginal distributions (%) of amino acids by position relative to the S/T-site 
Amino  
Acid 
Eight positions to the left/right of the S/T-site for O-GalNAc glycosylated sequences 
 -8 -7 -6 -5 -4 -3 -2 -1 +1 +2 +3 +4 +5 +6 +7 +8 
A 7.7 7.2 7.0 7.2 6.6 7.0 9.1 8.5 7.7 10.2 7.9 6.8 8.0 8.2 7.9 7.8 
C 0.9 0.8 0.9 0.4 0.8 0.4 0.4 0.1 0.9 0.1 0.3 0.4 0.7 0.6 0.7 1.4 
D 4.3 4.5 4.1 3.8 4.1 3.4 4.2 1.3 3.9 4.0 4.3 3.7 5.2 4.6 4.6 5.0 
E 6.4 6.2 6.6 6.8 6.4 8.3 6.6 4.4 7.0 6.2 5.2 7.0 7.8 6.6 7.1 8.0 
F 2.4 2.4 2.3 2.2 2.3 2.4 2.7 2.8 1.6 2.0 2.7 2.0 2.3 2.3 2.0 2.2 
G 6.9 6.7 6.9 6.8 6.2 5.2 7.6 5.3 5.6 7.2 6.0 6.8 6.1 7.6 7.8 6.8 
H 3.6 3.8 2.9 4.3 4.5 3.6 3.6 4.5 3.8 4.0 2.8 3.5 3.5 3.2 3.4 3.0 
I 2.9 3.2 2.7 3.0 3.6 3.4 3.0 3.2 2.4 2.7 2.3 2.7 3.2 2.1 2.0 2.3 
K 5.7 5.4 5.7 5.8 5.1 5.6 5.5 3.3 4.6 5.6 3.6 6.0 5.3 5.6 6.6 7.0 
L 6.8 7.1 6.7 7.2 6.8 8.0 7.1 5.6 7.5 7.1 6.1 6.7 7.2 7.7 7.1 7.0 
M 1.7 1.3 1.0 0.8 0.8 1.0 1.1 0.9 0.7 1.0 0.9 1.0 1.1 1.0 1.1 1.1 
N 2.1 2.0 2.5 2.4 2.1 2.0 1.2 1.7 1.7 2.6 2.1 2.0 2.2 2.2 2.3 2.6 
P 8.3 9.6 9.4 10.2 9.4 11.0 11.5 15.8 11.6 12.2 17.8 12.3 9.7 10.6 8.9 8.2 
Q 4.7 4.3 4.4 4.4 4.7 4.2 4.5 3.9 4.9 3.9 4.2 3.9 3.6 4.0 4.9 4.2 
R 7.5 6.5 7.5 7.2 7.5 6.8 6.2 5.1 5.9 5.8 4.7 6.5 6.9 7.5 6.7 6.8 
S 9.4 10.6 11.5 10.1 11.8 10.3 9.0 10.3 10.4 11.3 10.8 10.3 9.6 10.1 10.5 9.1 
T 11.5 10.8 10.6 10.2 10.1 8.3 8.0 11.2 12.0 6.8 10.9 10.2 9.5 9.7 10.0 10.4 
V 5.2 5.8 5.4 5.2 5.5 6.7 6.0 9.7 6.2 5.1 5.4 6.1 6.0 4.5 4.9 4.8 
W 1.0 0.6 0.5 0.8 0.5 0.9 0.8 0.5 0.6 0.7 0.5 1.0 0.6 0.5 0.5 1.3 
Y 1.3 1.4 1.2 1.4 1.5 1.6 1.8 1.7 1.2 1.5 1.7 1.4 1.4 1.5 1.3 1.3 
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Table 5: Marginal distributions (%) of amino acids by position relative to the S/T/Y/H-site 
Amino  
Acid 
Seven positions* to the left/right of the S/T-site for phosphorylated sequences 
-7 -6 -5 -4 -3 -2 -1 +1 +2 +3 +4 +5 +6 +7 
A 7 6.9 6.8 6.6 6.4 6.8 6.7 5.7 6.4 6.4 6.4 6.6 6.9 6.7 
C 1.4 1.4 1.3 1.2 1.2 1.3 1.3 1.2 1.4 1.2 1.3 1.3 1.3 2.5 
D 4.9 4.9 4.9 5 5 5.1 6.1 5.4 5.9 5.6 5.2 5.3 5.1 5.1 
E 7.3 7.3 7 7.2 6.8 6.6 6 6.6 9.5 8.5 7.8 7.6 7.8 7.5 
F 2.6 2.6 2.8 2.6 2.4 2.5 2.8 3.1 2.3 2.5 2.6 2.7 2.7 2.7 
G 6.9 6.7 6.6 7.1 6.8 6.7 8.1 7.6 6.9 7.1 6.5 6.6 6.6 6.5 
H 2.2 2.2 3.3 2.2 2.5 2.1 3.7 2 2 2.1 2.1 2.3 2.2 2.3 
I 3.6 3.7 3.6 3.5 3.4 4.1 3.9 3.6 3.5 3.5 3.8 3.5 3.6 3.5 
K 7.4 7.3 7 7.3 7.2 6.1 6 4.5 6 7.6 6.8 7.3 7.5 7.2 
L 7.9 8.3 8.8 7.7 8 8 9.1 9.1 7.9 7.8 8.7 7.9 8 8.1 
M 2.1 1.8 1.8 1.8 1.8 1.9 1.7 1.8 1.7 1.8 1.8 1.8 1.8 1.8 
N 3.4 3.4 3.4 3.5 3.3 3.8 3.8 2.6 3.3 3.4 3.3 3.3 3.3 3.4 
P 7.1 7 7 6.9 6.7 7.9 7.3 15.5 8 7.3 8.1 7.6 7.4 7 
Q 4.5 4.4 4.3 4.8 4.1 4.4 3.8 4.6 3.9 4.3 4.2 4.3 4.4 4.3 
R 7.4 7.5 7.7 7.3 11 7.3 6.8 5.1 6.1 6.8 6.4 6.9 7 7 
S 10.6 10.7 10.3 11.7 10.9 11.7 9.8 9.2 11.6 11.1 11.3 10.6 10.8 10.5 
T 5.7 5.5 5.3 5.4 5 5.7 4.4 4.1 5.9 5.1 5.7 5.5 5.6 5.5 
V 5.2 5.2 5.2 5.1 4.8 5.4 5.5 5.3 5.2 5 5.3 5 5.3 5.1 
W 0.8 0.7 0.7 0.7 0.6 0.6 0.6 0.8 0.5 0.7 0.7 0.7 0.7 0.8 
Y 2.2 2.2 2.2 2.1 2 2.1 2.3 2.1 2 2.1 2.1 3.2 2.1 2.5 
* Only seven positions to the left/right of the phosphorylation site were collected. 
 
While visual inspection of amino acids in the vicinity of these sites provide some indication 
of their preferences and charge distributions, a subjective analysis cannot be done. 
Therefore, statistical analysis of the data is done in this paper to provide more rigorous 
indications of the same. Empirical analysis suggests that given a set of sequences for a 
particular PTM of proteins, the proportions of an amino acid occupying positions (e.g., ±8 
from the S/T-site) along a sequence can discriminate between two PTMs of proteins. This 
is tested using the Wilcoxon signed-rank test [41] and the results are shown in Table 6. 
 
Table 6: Testing whether the proportions of an amino acid over the positions it occupies are  
 pairwise different across PTMs of proteins* 
 
Amino Acid 
A C D E F G H I K L M N P Q R S T V W Y 
O-GlcNAc  
vs  
O-GalNAc 
glycosylation 
1 0 1 1 1 0 1 1 0 0 0 0 1 0 0 1 0 1 1 1 
O-GlcNAc 
glycosylation  
vs  
phosphorylation 
1 1 1 1 1 0 0 0 1 1 1 1 0 0 0 0 1 1 1 0 
O-GalNAc  
glycosylation 
vs  
phosphorylation 
1 1 1 1 1 0 1 1 1 1 1 1 1 0 0 0 1 1 0 1 
* 1/0 indicates the difference is/isn’t statistically significant at the 5% level of significance. The first 
comparison uses the 16 pairs, while the other two uses 14 pairs. 
 
For example, in Table 3 and Table 5, the proportions of occurrence of amino acid F along 
seven positions to the left/right of the S/T- and S/T/Y/H- sites in O-GlcNAc glycosylated 
and phosphorylated sequences, respectively, appear different under pairwise comparison 
(i.e., the amino acid proportions along one row of one Table are compared, pairwise, with 
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the proportions of that same amino acid along the corresponding row of the other Table). 
The Wilcoxon signed-rank test is used to determine if these two sets of proportions are 
statistically different. As shown in Table 6, detected differences are flagged as “1” and by 
“0” otherwise. Table 6 indicates that using amino acids in the positions they occupy as 
“explanatory variables” to predict O-glycosylation is reasonable. In contrast, the 
proportions of amino acids in a particular position for one PTM process are not statistically 
different from the proportions of amino acids in that same position for another PTM 
process. For example, the Wilcoxon signed-rank test applied to compare, pairwise, the 
proportions in any column of Table 3 with those in the corresponding column of Table 4 
shows the pairwise differences are not statistically significant. This same result holds when 
comparing the columns of Table 3 with the corresponding ones in Table 5; and those of 
Table 4 with the corresponding ones in Table 5.  
 
Finally, it is of interest to know whether sequons involved in the PTMs of proteins are 
unique to each kind of PTM process. For example, given the consensus sequon for N-
glycosylation is N–X–S/T, one can find out if in the collected data there are N-glycosylated 
sequences that are also O-glycosylated or phosphorylated at the S/T-site, which is at the 2nd 
position to the right of N in this sequon. UniProt Accession numbers and UniProt position 
pairs are compared across PTMs. Because N-glycosylation occurs at N, the UniProt 
positions of N-glycosylated sequences, in the data, are increased by 2 so the S/T-sites can 
be compared across the other PTMs. In the empirical data, there are no N-glycosylated 
sequences with UniProt Accession No. and UniProt position + 2 pairs that match the 
UniProt Accession No. and UniProt position pairs of O-GlcNAc or O-GalNAc 
glycosylated sequences. This is as expected, because the structures of N- and O-linked 
oligosaccharides are very different, and reflect differences in their biosynthesis and cellular 
localizations. Thus, the N-linked site cannot be O-glycosylated at the S/T-site of the N–X–
S/T sequon. However, there is a small number of N-glycosylated sequences that are 
phosphorylated. Table 7 presents the counts of sequences in the empirical data that are 
common between the different PTMs of proteins considered herein (i.e., intersections of 
two sets of sequences are calculated). 
 
Table 7: UniProt Accession No. and position pair counts that are common between PTMs of proteins 
Sequences in the empirical data  
that are: 
N-glycosylated O-GlcNAc glycosylated O-GalNAc glycosylated Phosphorylated 
N-glycosylated 361 0 0 13 
O-GlcNAc glycosylated  638 0 144 
O-GalNAc glycosylated  2,079 224 
Phosphorylated  227,810 
 
Table 8 lists 13 proteins that are N-glycosylated at N and phosphorylated at the second 
position to the right of N, which is S/T. The majority of these proteins are receptors involved 
in signaling and are phosphorylated via a threonine residue. What roles these 
phosphorylation sites play require further analysis and experimentation. 
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Table 8: N-glycosylated sequences that are also phosphorylated 
UniProt 
Accession No. 
Protein Name 
Phosphorylated 
at UniProt position (residue) 
N-glycosylated 
at UniProt position 
O00206 Toll-like receptor 4  175 (T) 173 
O15455 Toll-like receptor 3 72 (T) 70 
P00533 Epidermal growth factor receptor 354 (T) 352 
P02675 Fibrinogen beta chain 396 (T) 394 
P02788 Lactotransferrin 499 (T) 497 
P04629 High affinity nerve growth factor receptor 123 (S) 121 
P05187 Alkaline phosphatase 273 (T) 271 
P06213 Insulin receptor 366 (S) 364 
P06213 Insulin receptor 447 (T) 445 
P07711 Cathepsin L1 223 (T) 221 
P12821 Angiotensin-converting enzyme 716 (T) 714 
Q96FE5 
Leucine-rich repeat and immunoglobulin-like  
domain-containing Nogo receptor-interacting protein 1 
295 (S) 293 
Q9NPH3 Interleukin-1 receptor accessory protein 113 (T) 111 
 
 
Modeling Strategy 
Because structural data on O-glycosylated sequences is sparse, two LPMs are estimated. 
One with sequence and structural data as explanatory variables. The other with only 
sequence data. The LPM has two principal sources of error: the exact process by which a 
protein becomes O-glycosylated is unknown; and uncertainty due to ambiguity in what 
constitutes a set of proteins that cannot be O-glycosylated. So, a suitable sequon is needed 
for discriminating between the two outcomes. 
 
Data (see Table 1) on three PTMs of proteins, increasing in sample size, is collected to 
identify a consensus sequon: O-GlcNAc glycosylation, O-GalNAc glycosylation, and 
phosphorylation, which is an important and pervasive PTM of proteins [42] that occurs, 
generally, at the S/T/Y-site. It has also been found to occur at the H-site [43]. Several 
sequons are tested to see if a consensus sequon exists. The outcome of these tests is shown 
in Table 9. As can be noted, the sequon W – S/T – W does not occur in the collected set of 
O-glycosylated sequences. Thus, ~ (W – S/T – W) is likely a consensus composite sequon 
for O-glycosylation, where, following Principia Mathematica [44], “~” denotes the “not” 
operator. This means there are 3 sequons that satisfy ~ (W – S/T – W): ~W – S/T – W,   W 
– S/T – ~W,   or   ~W – S/T – ~W.  
 
An important question is whether, as sample size increases, W – S/T – W continues not to 
occur at all in O-glycosylated sequences. The answer to this question has to wait until 
much larger sets of O-glycosylated sequences are available for study. In the meantime, one 
can approach this question in another way. The N – ~P – S/T sequon is considered a 
necessary [45, 46], but not sufficient, condition for N-glycosylation. This is another 
important PTM of proteins. Its likelihood is modeled in Gana et al. In the strictest sense, 
this is a true statement if the occurrence of P in the position between N and S/T is an 
“absolute” inhibitor of N-glycosylation [47] – i.e., if the N – ~P – S/T sequon is never 
observed in N-glycosylated sequences. However, this is not the case. Rather, the word 
“absolute” is used in a probabilistic sense: the fact that N – P – S/T occurs “rarely” is 
sufficient for N – ~P – S/T to be termed a “consensus” sequon. In particular, a partial search 
for the N–P–S/T sequons in UniProt revealed 23 such sequons associated with N-
glycosylated human proteins. In contrast, 16 (0.0066% + 0.004% = 0.007%) of the 227,810 
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phosphorylated human sequences in Table 9 have the W – S/T/Y/H – W sequon. Finally, a 
search of UniProt for human proteins with the W – S/T – W sequon yielded 236 sequences 
(in the WSTW-Uniprot dataset of Table 1). It is found that none of them are O-glycosylated 
at S/T. 
 
The sequon for C-linked glycosylation is W–X–X–W or W–S/T–X–C. Analysis of the data 
indicates that the presence of W immediately before and immediately after the S/T-site 
(S/T/Y/H-site) disallows O-glycosylation (phosphorylation). Furthermore, the occurrence 
of N two positions to the left of the S/T-site is relatively rare in O-glycosylation. Thus, 
nature appears to have evolved distinct sequons and amino acid propensities unique to each 
of the PTMs discussed herein. 
 
Table 9 indicates that the majority (98.54% + 0.24% = 98.78%) of O-GlcNAc glycosylated 
sequences have the ~N – X – S/T sequon. In contrast, these sequences having the N – ~P – 
S/T sequon is small (1.22%). Thus, for LPM estimation, the set of N-glycosylated 
sequences in Gana et al. [34] is considered to be a reasonable approximation for non-O-
glycosylated sequences. By discriminating between the features of O- and non-O- 
glycosylated sequences, respectively, the LPM estimates the likelihood of O-glycosylation. 
Because 1.22%, rather than 0%, of the O-glycosylated sequences have the N – ~P – S/T 
sequon, the ambiguity regarding what constitutes a set of sequences that cannot be O-
glycosylated has not been completely removed. However, that ambiguity has been 
considerably reduced. 
 
Table 9: Empirical occurrence rate of the identified sequon in PTMs of proteins 
Sequon* 
(viewed from S/T/Y/H as “center”) 
% of Sequences in the collected data that are: 
   
O-GlcNAc glycosylated O-GalNAc glycosylated Phosphorylated 
N – P – S/T 0.24% 0.43% 0.145% 
N – ~P – S/T 1.22% (0.5%, 2.8%) ** 
0.77% 
(0.5%, 1.2%) ** 
2.858% 
(2.8%, 2.9%) ** 
~N – X – S/T 98.54% (96.9%, 99.3%) ** 
98.80% 
(98.2%, 99.2%) ** 80.453% 
~N – X – Y Not applicable Not applicable 15.748% 
~N – X – H Not applicable Not applicable 0.006% 
~N – X – S/T/Y/H Not applicable Not applicable 96.2% (96.1%, 96.3%) ** 
W – S/T – W 0% 0% 0.0066% (0.004%, 0.011%) ** 
~W – S/T – ~W 100% 98.94% (98.4%, 99.3%) ** 82.3133% 
~W – S/T – W 0% 0.58% (0.33%, 1.0%) ** 0.6422% 
W – S/T – ~W 0% 0.48% (0.26%, 0.88%) ** 0.4930% 
W – Y/H – W  Not applicable Not applicable 0.0004% 
~W – Y/H – ~W Not applicable Not applicable 16.2587% 
W – Y/H – ~W Not applicable Not applicable 0.1365% 
~W – Y/H – W Not applicable Not applicable 0.1462% 
 
Sequence count 411 2,079 227,810 
*X denotes any amino acid. ** 95% confidence interval [48] 
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Using the data in Gana et al., O-GlcNAc glycosylation is modeled by including the amino 
acids in 8 positions to the right, and 8 positions to the left, of the S/T-site as possible 
explanatory variables. The collected data on N-glycosylated sequences described in Gana 
et al. [34] have 10 positions to the right, and 10 positions to the left, of the N-site. Because 
training the LPM to discriminate between O- and not O- glycosylated proteins must focus 
on the S/T-site as center for all proteins in the estimation dataset, only 8 positions to the 
right of S/T are available for use in that data. The remaining possible explanatory variables 
are the collected structural data on the proteins.  
 
When the LPM is applied to out-of-sample data, other types of O-glycosylated sequences 
may be a part of it. To assess the sensitivity of the mispredictions rate, the LPM of O-
GlcNAc glycosylation is applied to a sample of O-GalNAc glycosylated sequences. The 
modeling and validation strategy is summarized in Table 10. 
 
Table 10: Summary of the modeling/validation strategy 
Row Data used What the data is used for Outcome 
1 
The 998 sequences in 
dbogap-str and the 1,083 
sequences in glycos 
Predicting the likelihood of O-GlcNAc 
glycosylation with sequence and structural data    
2 
The 340 sequences in 
dbogap-seq and the 361 
sequences in Ngly 
Predicting the likelihood of O-GlcNAc 
glycosylation with only sequence data. A 
sequence is considered to be mispredicted if its 
predicted probability of O-glycosylation is less 
than 50% and it is O-glycosylated 
Table 14. About 11% of 
sequences in dbogap-seq 
are mispredicted as not 
being O-GlcNAc 
glycosylated; and 9% of 
the sequences in Ngly are 
mispredicted as being O-
GlcNAc glycosylated 
3 The 259 sequences in Oglc-non-dbogap 
Calculating the out-of-sample mispredictions 
rate with the LPM estimated for the exercise 
outlined in Row 2 of this Table  
54 of the 259 sequences (≈ 
21%) are mispredicted as not 
being O-GlcNAC 
glycosylated 
4 The 2,079 sequences in Ogal 
Calculate the out-of-sample mispredictions rate 
with the LPM estimated for the exercise 
outlined in Row 2 of this Table  
656 of the 2,079 (≈ 31.6%) 
are mispredicted as not being 
O-GalNAc glycosylated 
5 The 236 sequences in WSTW-Uniprot To see if any of these are O-glycosylated 
None are O-glycosylated. 
This again indicates that 
~ (W – S/T – W) is likely 
necessary for O-
glycosylation 
 
Estimating the two LPMs 
LPM predictions using sequence and structural data 
Based on the collected data (glycos_public.xlsx), as in Gana et al.[34], the ith position to 
the left (right) of S/T is minusi (plusi). If amino acid α occupies i, then: minusiα = 1 if α is 
to the left of S/T and plusiα = 1 if α is to the right of S/T; otherwise, these indicator variables 
take the value 0. Thus, 140 (20 × 8 – 20) and 160 (20 × 8) indicator variables define the 
left and right neighborhoods of S/T, respectively. The ratio (posj) of the position of the 
glycosylation site (S/T or N) to the total length of protein j is also assumed to be an 
explanatory variable. Finally, it is assumed that the structural information on the sequences 
are additional explanatory variables. 
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Let Yj be the binary dependent variable that takes the value 1 if sequence j is O-glycosylated 
and 0 if it is not (N-glycosylated). Then, the postulated LPM (indexed as EQ1) is:   
Yj = β0 + Σα Σi ≠ 2 βiα minusiα + Σα Σi φiα plusiα + λ posj + δ ASAj +  π (ASA_zeroj) +  
Σk θk (Turn Typek ) + ω1 (psi angle) + ω2 (phi angle)  (EQ1) 
where β0 , βiα , φiα , λ , δ , π , θk , ω1 and ω2 are constants (coefficients) estimated using the 
data; Σα , Σi  denote summations over significant amino acid and position combinations, 
respectively, and Σk denotes summation over significant turn types. The variable ASA_zero 
is a dummy variable that takes the value 1 if ASA is zero, and 0 otherwise. Minus2α is 
dropped so as not to bias the LPM, because the set of non-O-glycosylated proteins only has 
an N (i.e., there is no amino acid variation, by design) at minus 2. Thus, retaining Minus2α 
with α ≠ N will flag amino acids (other than N) present at minus 2 only whenever Yj = 1, 
which would be inappropriate. Amino acids A, D, F and K dominate the 998 human 
proteins at minus 2; and D, F, K, R and S dominate the remaining 107 non-human proteins. 
The set of O-glycosylated sequences have no N at minus 2. Also, note that OOS_wstw is 
not used as the set of non-O-glycosylated sequences, because it will lead to the perfect, but 
trivial, model: Yj = 1 – minus1W. In this case, one option is to estimate the LPM by ignoring 
the amino acids on either side of the S/T-site. However, this does not improve LPM 
predictive capability materially. More importantly, it would be of interest to find sequences 
with the W–S/T–W sequon that do “something” (e.g., C-glycosylation with W–S/T–W–W 
or W–S/T–W–C sequons) rather than “nothing” (or staying “silent”); and then refit the LPM 
to see how well it discriminates between O-glycosylated and non-O-glycosylatable 
sequences. In addition, if structural data is included for LPM estimation, solid predictive 
power would likely be the outcome. 
  
The selected LPM, shown in Table 11, is estimated on 1,083 (human) N-glycosylated 
proteins and 987 O-glycosylated proteins. As in Gana et al. [34], N-glycosylated sites with 
a single sugar are deleted from the estimation data because these may be false positives 
given the known artifacts from crystallization. As detailed in Gana et al. [34], the LPM is 
selected using the stepwise selection method [49-51] in conjunction with 10-fold cross-
validation [52-56] to minimize the prediction residual sum of squared errors (PRESS), 
which has a point of contact with the Brier Score [57, 58] . Because the LS estimated LPM 
produces heteroscedastic errors (i.e., residuals with varying variances), it was confirmed 
that stepwise selected significant variables continued to remain significant when 
reevaluated in terms of heteroscedasticity-consistent standard errors [59], as a first 
approximation. Because the exact functional form of the LPM error variance is known, RR 
is applied to the stepwise selected LPM to reconfirm that all variables continue to be 
statistically significant. This is done by re-estimating the stepwise selected LPM by RR so 
the predicted values of Yj are forced to lie in [60] the 0-1 interval and estimating the error 
variances [29]: (RR predicted Yj ) × (1 – RR predicted Yj ). The optimal value of the RR 
tuning parameter, k, for which all of the aforesaid predictions fall in the range 0-1 is 
3.77895. Using these variances as weights, the LPM is re-estimated using classical 
weighted LS (WLS). If variables with p-values greater than 5% result, the entire LPM 
estimation process is redone until all variables are significant at 5%. 
 
The number of amino acid and position combinations found to be significant in the selected 
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LPM is 76. Model parsimony (e.g., favoring retaining fewer, rather than more, explanatory 
variables) is not sought, because it is not at all clear that Nature is “inefficient”, or provides 
redundant information, by making irrelevant the placement of certain amino acids in certain 
positions along the sequence. The selected LPM yields an in-sample Kolmogorov-Smirnov 
(KS) statistic of about 99.2%, which signals a reasonable degree of discrimination between 
O- and non-O- glycosylated proteins. The maximum separation for the KS statistic [61-65] 
occurs at the predicted probability value of about 43%. The average (in-sample) predicted 
probabilities of O-glycosylation when Yj = 0 and Yj = 1 are about 1% and 98%, respectively. 
The standard deviations of predicted probabilities of O-glycosylation when Yj = 0 and Yj = 
1 are about 11% and 7%, respectively. The Durbin-Watson (DW) statistic [66, 67] for the 
LPM is about 1.5.  
 
Table 11: LPM predicting O-glycosylation probabilities given structural and sequence data 
Variable* β |t| Variable* β |t| Variable* β |t| 
intercept -0.1309 9.71 m8N -0.0921 4.18 p7T -0.1431 9.24 
m1D 0.1878 10.74 m8P -0.1516 11.05 p7V -0.1309 8.14 
m1L 0.0861 7.26 m8V -0.2180 12.08 p7Y 0.1290 6.75 
m1P 0.7885 11.63 p1A 0.1778 9.83 p8H 0.1164 5.76 
m1R -0.0757 4.66 p1D 0.0915 4.67 p8K 0.0570 3.34 
m3A 0.2162 14.35 p1F 0.0858 5.44 p8N 0.1003 5.51 
m3C -0.1315 6.45 p1S 0.0835 5.33 p8Q 0.1493 8.53 
m3L -0.1139 9.49 p1T 0.1673 10.15 pos 0.2821 15.95 
m3N -0.2245 5.86 p1V 0.0669 4.97 ASA_zero 0.8057 12.02 
m3T -0.0881 5.14 p2A 0.0590 2.92 II 0.1649 6.95 
m4E 0.1296 5.3 p2H 0.3143 11.32 II´ -0.2828 7.58 
m4F -0.0848 5.56 p2P 0.2652 18.99 Helix 0.1610 14.88 
m4N 0.1419 7.3 p2Q -0.1532 7.89 Beta Bridges 0.6077 6.53 
m4R 0.1410 7.04 p2Y -0.2434 8.12 Beta Hairpin 0.7884 22.3 
m4V -0.0545 4.18 p3N -0.1615 7.69 Beta Hairpin Strand -0.1044 9.83 
m5D 0.2521 13.74 p3W -0.1086 3.41 Phi angle -0.0004 5.31 
m5F -0.1257 6 p4A 0.1629 9.62  
m5G 0.0700 3.21 p4E 0.1757 12.53 
m5I -0.0981 4.85 p4P 0.1921 13.35 
m5Y -0.1468 6.9 p5C -0.1957 9.63 
m6E 0.0954 7.08 p5E 0.1718 7.98 
m6H -0.1245 4.73 p5H 0.1938 7.88 
m6V 0.1528 9.82 p5I -0.0760 4.33 
m6W 0.1166 4.9 p5Q 0.1060 4.93 
m6Y -0.1265 6.31 p5T 0.0722 4.61 
m7A 0.1576 10.18 p5Y -0.1876 7.45 
m7E -0.1132 6.87 p6F -0.1155 5.43 
m7G -0.0685 4.89 p6G -0.1696 10.07 
m7H 0.2427 11.33 p6M 0.3118 9.57 
m7I 0.1222 7.67 p6N -0.1209 6.67 
m7K 0.1538 8.77 p6Q -0.2641 12.26 
m7S 0.0826 4.44 p7A 0.1752 7.04 
m8G 0.1032 6.68 p7C -0.1281 5.86 
m8L -0.1541 10.43 p7E -0.1161 7.36 
m8M -0.1234 5.34 p7G -0.0951 5.81 
     * miα and piα are abbreviations for minusiα and plusiα, respectively. Note that the coefficient 
        standard error is β ÷|t|. 
   
 
The nine mispredictions made by the LPM, in-sample, are documented in Table 12. The 
accessions in Table 12 are not annotated in UniProt to be glycosylated except for Q16566 
(O-linked), Q92854 (N-linked), and P31749 (phosphorylated). Thus, how many sequences 
in Table 12 are truly false positives, remains to be seen. 
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Table 12: LPM mispredictions in-sample, using 50% as the cutoff probability 
UniProt 
Accession 
No. 
UniProt 
Position 
Protein 
Length 
Sequence 
Secondary 
Structure 
Turn 
Type 
Phi 
angle 
Psi 
angle 
ASA 
LPM 
prediction 
Proteins with LPM predictions < 50%, but that are deemed to be O-glycosylated in the data 
P02730 224 911 ILEKIPPDSEATLVLVG Beta Turn IV -113 168 18.8 19.3% 
Q16566 57 473 ESELGRGATSIVYRCKQ Beta Turn I -83 -35 69.9 34.6% 
P16157 794 1881 LKVVTDETSFVLVSDKH 
Gamma 
Turn, Beta 
Turn 
Inverse, 
IV 
-54 11 94.7 36.3% 
P68431 11 136 RTKQTARKSTGGKAPRK Loop N/A -81 145 44.4 36.3% 
P31749 308 480 IKDGATMKTFCGTPEYL Loop N/A -115 -3 47.6 44.5% 
P04406 229 335 IPELNGKLTGMAFRVPT Strand N/A -157 171 55.5 44.5% 
Proteins with LPM predictions > 50%, but that are deemed to be N-glycosylated in the data 
P06756 
488 
SA 
1048 SILNQDNKTCSLPGTAL 
Gamma 
Turn, Beta 
Turn 
Inverse, 
IV 
-69 93 63.5 51.6% 
P04629 329 796 THVNNGNYTLLAANPFG 
Beta 
Hairpin 
Strand 
N/A -93 119 30.7 62.7% 
Q92854 329 862 SAVCAYNLSTAEEVFSH 
Beta 
Hairpin 
Strand 
N/A -76 124 35.5 70.1% 
 
It has been observed that amino acid P is usually present around O-glycosylation sites; and 
that O-glycosylation tends to occur more in the beta-strands of proteins [68, 69]  indicating 
the significance of proline around the S/T-site. However,  indicates that the likelihood of 
O-glycosylation tends to be more favorable in the beta hairpins and beta bridges of proteins. 
In  ASA_zero is significant. This appears to be “unusual” because only 2 sequences in the 
LPM estimation data, both of which are experimentally deemed to be O-GlcNAc 
glycosylated, have ASA values of 0. ASA_zero has a point of contact with the concept of 
an “observation-specific” dummy variable [70-73]. The two sequences with ASA values 
of 0 are shown in Table 13. An important biological question is whether sequences not 
exposed at all, but with other O-glycosylation friendly characteristics, have a greater 
propensity to be O-glycosylated.  
 
Table 13: Sequences in the LPM estimation dataset for which ASA values are zero 
UniProt 
Accession 
No. 
UniProt 
Position 
Protein 
Length 
Sequence 
Secondary 
Structure 
Phi 
angle 
Psi 
angle 
PDB 
ID 
LPM 
prediction 
P02730 162 911 ELLRALLLKHSHAGELEALGG Strand -68.8 160.7 1HYN 89.3% 
P32119 112 198 PLLADVTRRLSEDYGVLKTDE Helix -60.1 40.0 1QMV 110.8% 
 
The two proteins Peroxiredoxin-2 (P32119) and Band 3 anion transport protein (P02730) 
have their O-linked glycosylation sites buried as indicated by their zero ASA values. While 
an explanation for this is not immediately apparent, position 112 in Peroxiredoxin-2 
(P32119) is a phosphorylation site as well. A question is whether the site is buried in order 
to make itself amenable to switch between the two processes via a conformational change 
(O-linked and Phosphorylation). Further research is needed to answer this question. 
 
ASA is not significant in the LPM. As the two data subsets of sequences in the LPM 
estimation dataset are either O- or N- glycosylated, it appears that differences in ASA, 
between N- and O- glycosylated sequences does not rise to the level of a predictor variable 
in the fitted LPM. The empirical cumulative probability distribution functions (CDFs) for 
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ASA, by estimation data subset, is shown in Figure 2. The mean/median ASA values, shown 
in Figure 2, differ by LPM estimation data subset. In particular, it appears that ASA values 
for N-glycosylated sequences are generally “larger” than those for O-GlcNAc glycosylated 
sequences. Interestingly, the Wilcoxon rank sum test [41] indicates that the ASA value for 
N-glycosylated sequences is “stochastically larger” [74] than the ASA value for O-GlcNAc 
glycosylated sequences. The p-value of this test is about 3.6%. If the KS test is applied, the 
p-value drops to nearly zero (3.96e-13). However, because the first p-value is less than 5%, 
it would be of interest to retest this phenomenon with larger data to see if one can get 
significantly lower p-values, say less than 0.5% [75] with the Wilcoxon rank sum test.  
 
Figure 2: Empirical CDFs of ASA values 
LPM predictions using only sequence data 
The LPM in Table 14 employs only sequence data. The optimal value of k for which all 
predictions are in the 0-1 range is 1.4357. With this k, the LPM in Table 14 is estimated by 
WLS and produces a KS statistic of about 80.4%, which is a steep drop from 99.2% and 
underscores the germaneness of structural information. Absent 3D structure, this loss in 
LPM predictive power is not surprising, considering that the same site is used by two 
fundamental PTM processes driven by conformational flexibility. Maximum separation 
occurs at the predicted probability value of about 49%. The DW statistic value is about 
1.12, indicating, as expected, missing explanatory variables (e.g., structural information) 
in the LPM as specified. This LPM produced only one prediction outside the 0-1 range 
flagging a protein deemed to be O-glycosylated in the data with a negative (or zero) 
“probability” (≈ –7.2%) of O-glycosylation; its UniProt Accession No., UniProt position, 
protein length, and sequence are Q16566, 58, 473, and VESELGRGATSIVYRCKQKGT, 
respectively. The LPM in Table 14 mispredicts (using 50% as the cutoff probability) 54 of 
the 259 (or 20.85%) out-of-sample O-GlcNAc glycosylated sequences as not being O-
GlcNAc glycosylated. The 95% confidence interval [48] around 20.85% is: (16.35%, 
ASA  
Pr
o
ba
bi
lit
y 
        Mean    Median 
         ASA      ASA 
N-glycosylated         53.5     53.3 
O-GlcNAc glycosylated    51.6       49.5  
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26.20%). If the LPM in Table 14 is applied to a sample of O-GalNAc glycosylated 
sequences, it mispredicts 656 of the 2,079 (or 31.6%) as not being O-GalNAc glycosylated. 
A LPM specific to O-GalNAc glycosylation will decrease the mispredictions rate. If the 
LPM in Table 14 is applied to the WSTW-Uniprot dataset (by ignoring the amino acids on 
either side of the S/T-site), 52 of the 236 (≈ 22%) sequences are mispredicted as being O-
glycosylated. As expected, this is slightly more than 20.85%.  
  
Table 14: WLS estimated LPM for predicting the probability of O-glycosylation given only sequence data 
Variable* β |t| Variable* β |t| 
intercept 0.1379 3.27 p1S 0.2446 5.33 
m1C -0.2020 2.11 p1T 0.2268 4.48 
m1F -0.1373 1.96 p2A 0.2120 4.44 
m1P 0.4708 5.44 p2D 0.2029 2.73 
m1T 0.1535 3.25 p2F -0.2292 2.43 
m1V 0.1348 3.41 p2G 0.1706 3.01 
m3F -0.1950 2.92 p2L -0.1342 2.64 
m3L -0.1367 2.65 p2S 0.2068 4.69 
m3P 0.1852 4 p3Q 0.1914 3.12 
m3V 0.1103 2.3 p3S 0.1041 2.29 
m4C -0.6595 4.9 p4A 0.2149 3.66 
m4F -0.2551 4.1 p4G 0.2195 3.93 
m4L -0.1180 2.28 p4S 0.1277 3.07 
m4Q -0.2802 4.52 p4T 0.1867 3.81 
m4V -0.2253 4.37 p5A 0.0934 1.77 
m4Y -0.2037 3.03 p5C -0.3927 4.63 
m5A 0.1224 2.28 p5L -0.1029 2.04 
m5C -0.2515 2.6 p5N -0.3141 3.6 
m5H -0.3195 3.45 p5W -0.7183 3.72 
m5N -0.2492 2.9 p6C -0.3787 4.2 
m5R 0.1419 2.57 p7A 0.1763 2.71 
m5W -0.2752 1.96 p7C -0.2791 3.06 
m5Y -0.1507 2.15 p7G 0.1366 2.5 
m6R 0.1362 2.31 p7K 0.1578 2.73 
m6Y -0.2011 2.49 p7T 0.1968 3.98 
m7L -0.0910 1.86 p8F -0.1867 2.86 
m7M -0.2490 2.83 p8S 0.1625 3.5 
m7R 0.2907 4.38 pos 0.2406 4.35 
m8A 0.1563 2.7  
m8K 0.1726 2.9 
p1A 0.2092 3.78 
p1G 0.1706 3.23 
p1K 0.2524 3.37 
p1P 0.4464 3.26 
p1Q 0.1728 3.05 
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Concluding Remarks  
In order to clarify why the LPM methodology used herein is appropriate, we discuss several 
points in a question-answer format, in this section. 
 
Is the LPM a valid methodology to model a binary response? 
The short answer is “yes”. However, a longer answer is needed because it is quite 
unfashionable to use the LPM these days. And that perception needs to be addressed.  
 
The LPM is fairly well-known to econometricians and statisticians [28, [76-81] and has 
sparked a fairly substantial literature. The LPM is Y = Xb + u, but where Y only takes the 
values 0 and 1. If E(u) = 0, then each ui has variance E(Yi)(1 – E(Yi)). Goldberger [28] 
suggested estimating E(Yi) by ordinary LS (OLS), and then re-estimating the model by 
WLS to achieve homoscedasticity (i.e., constant residual variance) with E(Yi)(1 – E(Yi)) as 
the “weights”. The primary attraction of the LPM is its simplicity. In large samples, the 
non-normality of u does not matter. The LPM produces consistent coefficients [32]. And 
the problem of getting predictions that lie outside the 0-1 range is not an asymptotic one 
[33]. Yes, “probabilities” less than 0 or greater than 1 can hinder empirical work with finite 
samples; but, only if those probabilities, per se, are used for something. In our case, 
probabilities less than 0 are interpreted as nearly 0 and those greater than 1 as nearly 1. 
This is so, because we are only interested in whether or not a sequence is O-glycosylated 
by assessing whether or not its probability of O-glycosylation is greater or less than 50%, 
respectively. The numerical value, per se, of the estimated probability of O-glycosylation 
below or above this threshold does not matter to us.   
  
Rounding LPM predictions that are less than 0 to a small number close to 0 (e.g., 0.001), 
and those greater than 1 to a number close to 1 (e.g., 0.999), is a well-known method to 
constrain the LPM predictions within the 0-1 range. In another approach, the sum of 
squared errors is minimized subject to the constraints 0 ≤ Xb ≤ 1 [82]. OLS LPM 
predictions are used to reestimate the LPM using WLS to overcome the problem of 
heteroscedasticity. Another method uses the absolute values of the weights to do WLS 
estimation. Another method  uses only OLS predictions that are in the 0-1 range to do WLS 
estimation [83]. In another method, the weights are bounded and negative weights are 
assigned a constant value [84]. Another method generalizes the last two methods ([85], 
[84], [86]). A limitation of these methods is that their sampling properties are not available. 
So, we use RR to construct the weights [29].  
 
To avoid the problem, in finite samples, of LPM estimates falling outside of the 0-1 range, 
logistic regression is a greatly favored alternative to the LPM [87]. The logit model 
mathematically forces the estimates of Y to lie in the 0-1 range by the transformation: log(Y 
÷ (1 – Y)) = Xb + u; and then estimates Y. In contrast, an alternative transformation is to 
use RR to force the estimates of Y in the 0-1 range. However, there is no a priori reason 
that says one way of constraining the estimates of Y to behave like “probabilities” is 
“superior” to the other. Furthermore, given that most of the predictors in our model (EQ1) 
are also binary variables, it is not at all clear that Nature prefers the likelihood of O-
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glycosylation to vary along an ogive- or sigmoid- like surface, rather than linearly. Nature’s 
preference is even less clear when most of the predictors, as in our case, are 0-1 dummies. 
 
This naturally leads to the question of whether our fitted model satisfies the assumptions 
of a linear model. For the LPM, the error (residual) term is never normal; rather it is 
binomial. Furthermore, the error term is not observable – we only observe the final binary 
outcome in Nature. For large samples the central limit theorem  guarantees that LPM errors 
converge to a normal distribution [88]. Although LPM errors are not observable, one way 
to approximate them is to simply compute them like in ordinary linear regression with a 
continuous dependent variable – i.e., take the difference of the binary dependent variable, 
Y, and the corresponding LPM prediction; and compute the average squared error, which 
is the Brier Score. For our model in Table 11, Figure 3 indicates that our sample size is 
approximately normal with a concentration of small errors in the range –0.04 to +0.04. A 
normal distribution with a mean of about 0.0025 (which is close to 0) and a standard 
deviation of about 0.1 fits Figure 3 approximately.           
 
 
Figure 3: Distribution of (unobservable) errors for the LPM in Table 11 
 
Cook’s distance is used to test for the presence of outliers [89, 90]. We use the rule of 
thumb that Cook’s distances (Ds) greater than 0.5 may be problematic. Cook’s D are shown 
in Figure 4, which indicates that the assumption of no outliers is a satisfactory one. 
 
 
Figure 4: Cook’s distances for the LPM in Table 11 
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In the LPM, a unit increase in an independent variable, holding the other independent 
variables at fixed values, leads to a constant increase in the dependent variable. Because 
most of our independent variables in the LPM are binary, this is indeed the case. However, 
for the two continuous variables, the question is whether this constant “partial derivative” 
or “marginal” effect of an independent variable on the dependent variable holds. In a logit 
model, for example, this marginal effect varies with the independent variable. A plot of the 
residuals versus the two continuous variables in our LPM in Table 11 is shown in Figure 
5. This plot indicates fairly random scatters. Thus, the constant linear marginal effect 
assumption is satisfactory. 
 
 
Figure 5: LPM residuals vs. pos and phi angle 
  
The LPM is a heteroscedastic model by construction. We first used White’s procedure [58] 
to correct for it. This LS estimated LPM with its heteroscedasticity consistent |t| values is 
shown in Table 15.  
 
  
pos phi angle 
re
sid
u
a
l 
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Table 15: LS estimated LPM predicting O-glycosylation probabilities given structural and sequence data 
Variable* β White’s |t| Variable* β White’s |t| Variable* β White’s |t| 
intercept -0.1177 5.17 m8N -0.0842 3.18 p7T -0.1371 6.97 
m1D 0.1827 5.30 m8P -0.1387 6.82 p7V -0.1173 4.68 
m1L 0.0930 3.71 m8V -0.2103 7.60 p7Y 0.1188 4.05 
m1P 0.7844 13.86 p1A 0.1754 5.59 p8H 0.1194 2.51 
m1R -0.0619 2.34 p1D 0.0984 2.65 p8K 0.0484 1.52 
m3A 0.2046 8.22 p1F 0.0831 2.43 p8N 0.1052 3.22 
m3C -0.1245 4.37 p1S 0.0884 3.27 p8Q 0.1466 4.52 
m3L -0.1099 6.18 p1T 0.1567 4.59 pos 0.2509 8.51 
m3N -0.2151 3.23 p1V 0.0623 3.34 ASA_zero 0.7952 9.89 
m3T -0.0743 2.90 p2A 0.0697 1.33 II 0.1387 3.12 
m4E 0.1109 2.61 p2H 0.2885 4.65 II´ -0.2684 4.04 
m4F -0.0881 3.43 p2P 0.2730 9.84 Helix 0.1508 7.66 
m4N 0.1405 3.27 p2Q -0.1379 4.70 Beta Bridges 0.6330 9.35 
m4R 0.1408 3.71 p2Y -0.1906 3.98 Beta Hairpin 0.8016 13.87 
m4V -0.0560 2.91 p3N -0.1483 5.13 Beta Hairpin Strand -0.0916 5.34 
m5D 0.2333 6.89 p3W -0.1152 3.37 Phi angle -0.0003 3.04 
m5F -0.0941 2.85 p4A 0.1650 4.77  
m5G 0.0560 1.75 p4E 0.1711 6.75 
m5I -0.0872 2.61 p4P 0.1946 8.26 
m5Y -0.1326 4.60 p5C -0.1742 5.23 
m6E 0.0916 3.22 p5E 0.1512 4.93 
m6H -0.1270 5.34 p5H 0.2173 4.08 
m6V 0.1567 3.99 p5I -0.0783 3.52 
m6W 0.1063 2.81 p5Q 0.1209 3.16 
m6Y -0.1267 4.11 p5T 0.0651 2.79 
m7A 0.1622 5.51 p5Y -0.1818 4.60 
m7E -0.1072 4.70 p6F -0.0883 1.97 
m7G -0.0703 3.42 p6G -0.1561 5.14 
m7H 0.2640 5.12 p6M 0.3066 4.87 
m7I 0.1141 5.62 p6N -0.1144 5.29 
m7K 0.1366 3.55 p6Q -0.2447 7.92 
m7S 0.0859 2.72 p7A 0.1803 3.10 
m8G 0.0964 4.51 p7C -0.1207 3.99 
m8L -0.1518 5.28 p7E -0.1148 4.67 
m8M -0.1187 4.49 p7G -0.0945 3.50 
 
Because the form of the heteroscedasticity in the LPM is known, we had also used WLS to 
correct for it. This was done by estimating Y by RR in such a manner so as to guarantee 
that the predicted Y lies in the unit interval [29]. The plots of the actual observations (which 
are binary) vs. the RR predictions and the final WLS predictions of our model in Table 11 
are shown in the left-hand and right-hand panels of Figure 6, respectively. 
 
 
 
Figure 6: Actual vs. predicted outcomes of the LPM in Table 11  
Y 
RR predicted Y (first stage LPM) WLS predicted Y (second stage LPM) 
KS: 96.7% 
Brier score: 0.0844 
KS: 99.2% 
Brier score: 0.0094 
Y 
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The RR predicted Y in the left-hand panel of Figure 6 was used to estimate the LPM 
residual variances (this is the “first stage” LPM), so the problem of non-constant variances 
in the LPM could be corrected for by using WLS. As can be visually observed in the left-
hand panel, all predictions are constrained to lie in the 0-1 range for the smallest value of 
k [29]. That is, similar to logistic regression, a mathematical constraint has been imposed 
on the predicted Y. In logistic regression this is done via a transformation; here it is done 
by constraining the estimated coefficients. It is also known [30, 31] that the RR predicted 
LPM (in the left-hand panel of Figure 6) is also a competitive model. That is, one does not 
necessarily have to compute the predictions in the right-hand panel of Figure 6, because 
RR has the capability to account for non-constant residual variances [30]. The thing to note 
is that the KS drops and the Brier score increases in the left-hand panel of Figure 6 relative 
to the corresponding values in the right-hand panel [57]. This may be interpretable as the 
“cost” for constraining the predicted Y to lie in the 0-1 range, rather than leveraging the 
asymptotic property that predictions outside the 0-1 range do not matter in large samples. 
 
What is the RR estimated LPM ANOVA? 
The RR estimated LPM that generated Figure 6 is shown in Table 16. The RR estimated 
standard errors for the coefficients are also shown in Table 16. Because RR produces non-
integer degrees of freedom, unlike in classical LS estimation, the resultant RR analysis of 
variance (ANOVA) table is shown in Table 17 [91]. Note that the RR estimated mean 
square error (MSE) is about 0.0827, which is very much like the Brier Score in the left-
hand panel of Figure 6. RR produces an approximate, but not exact, F-ratio (for non-
stochastic k) in the ANOVA table in Table 17, which is about 341 [92]. The angle between 
the regression vector and the residual vector is about 37⁰, which measures “how much the 
residual vector deviates from being orthogonal to the X space as it is in least squares” [95] 
[93].  
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Table 16: RR estimated LPM predicting O-glycosylation probabilities given structural and sequence data 
Variable β 
Standard 
error 
Variable β 
Standard 
error 
Variable β 
Standard 
error 
intercept 0.3124 0.0322 m8N -0.0595 0.0496 p7T -0.0660 0.0364 
m1D 0.0343 0.0415 m8P -0.0638 0.0336 p7V -0.0556 0.0386 
m1L 0.0560 0.0307 m8V -0.0687 0.0433 p7Y 0.0463 0.0439 
m1P 0.1345 0.0687 p1A -0.0119 0.0435 p8H 0.0487 0.0459 
m1R -0.0671 0.0391 p1D 0.0614 0.0474 p8K 0.0037 0.0409 
m3A 0.0127 0.0368 p1F 0.0657 0.0396 p8N 0.0638 0.0428 
m3C -0.0633 0.0473 p1S -0.0007 0.0383 p8Q 0.0082 0.0414 
m3L 0.0228 0.0316 p1T 0.0664 0.0391 pos 0.0338 0.0417 
m3N -0.0528 0.0703 p1V -0.0329 0.0323 ASA_zero 0.1204 0.0690 
m3T -0.0515 0.0406 p2A 0.0554 0.0465 II -0.0266 0.0547 
m4E -0.0219 0.0543 p2H 0.0169 0.0592 II´ -0.0616 0.0678 
m4F 0.0251 0.0377 p2P 0.0788 0.0349 Helix 0.0603 0.0271 
m4N 0.0548 0.0464 p2Q -0.0658 0.0444 Beta Bridges 0.1283 0.0588 
m4R 0.0669 0.0476 p2Y -0.0701 0.0602 Beta Hairpin 0.1353 0.0689 
m4V -0.0619 0.0309 p3N -0.0574 0.0469 Beta Hairpin Strand -0.0641 0.0264 
m5D 0.0553 0.0444 p3W -0.0584 0.0619 Phi angle 0.0001 0.0002 
m5F -0.0751 0.0465 p4A 0.0642 0.0406  
m5G -0.0351 0.0482 p4E 0.0139 0.0350 
m5I -0.0408 0.0478 p4P 0.0384 0.0359 
m5Y -0.0577 0.0482 p5C -0.0702 0.0473 
m6E 0.0249 0.0338 p5E -0.0222 0.0471 
m6H -0.0693 0.0579 p5H 0.0701 0.0540 
m6V 0.0545 0.0395 p5I -0.0552 0.0419 
m6W 0.0067 0.0525 p5Q 0.0310 0.0511 
m6Y -0.0589 0.0450 p5T -0.0380 0.0371 
m7A 0.0418 0.0381 p5Y -0.0697 0.0546 
m7E -0.0655 0.0398 p6F -0.0644 0.0482 
m7G -0.0569 0.0348 p6G -0.0540 0.0418 
m7H 0.0707 0.0491 p6M 0.0608 0.0620 
m7I -0.0053 0.0385 p6N -0.0695 0.0438 
m7K 0.0396 0.0409 p6Q -0.0782 0.0484 
m7S -0.0403 0.0433 p7A 0.0765 0.0562 
m8G 0.0512 0.0390 p7C -0.0576 0.0493 
m8L -0.0587 0.0351 p7E -0.0513 0.0393 
m8M -0.0693 0.0525 p7G 0.0306 0.0383 
  
 
Table 17: RR estimated LPM ANOVA with k = 3.77895 
Source Degrees of Freedom 
Sum of 
Squares 
Mean 
Square 
Approximate 
F-Ratio Angle 
Regression 4.2906 121.1983 28.2472 
341.4085 37.82⁰ 
Residual 2043.1994 169.0489 0.0827 
Nonorthogonal component 
(NON) 21.5099 226.1397 
 
Total 2069 516.387 
 
 
Is the lasso penalized logit model (LPLM) more appropriate than the LPM to estimate Y? 
The concept of the “lasso” penalty to model a dataset in which the number of predictors 
exceeds the number of observations goes back, at least, to the 1970s [94-96]. Later it was 
made fashionable by describing its applicability to statistical model selection [96].  
 
The LPLM is estimated by minimizing the negative log-likelihood function, L(·), subject 
to the constraint that the sum of the absolute values of the coefficients is less than or equal 
to some value – that is, ||b||1 ≤ t, where log[(Pr(Y=1) ÷ (1 – Pr(Y=1))] = Xb and ||v||p 
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denotes the “p-norm” of a vector v. In contrast, RR uses the constraint (||b||2)2 ≤ t.  That is, 
the sum of squared coefficients, instead of absolute coefficients, is constrained. In 
Lagrangian form [97, 98], the LPLM optimization problem can be recast as: minimize  
–L(·) + λ × sum(|b|). This minimization is done using Nesterov’s method [99]. Here, a 
regularization parameter, ρi, where 0 < ρ < 1 and i is the ith step in Lasso selection, is used 
for λ in the ith step. Variable subset selection, via the Lasso, is done, using up to 200 steps, 
so as to minimize the Schwarz Bayesian Criterion (SBC) [100]. In sample, several LPLMs 
are estimated for different values of ρ and the resultant number of variables (excluding the 
intercept) selected, the KS statistic values, the Brier Scores, and twice the negative log-
likelihood values are shown in Table 18. In terms of the SBC, the “optimal” LPLM, on the 
full sample, is the one with ρ = 0.815; and this is also nearly “optimal” in terms of Brier 
Score and KS statistic value. To assess LPLM performance out of sample as ρ varies, 5-
fold cross validation (CV) is done. LPLMs are fit on a set of 4 “training” folds and the 
Brier Score is calculated on the holdout fold. Thus, for a particular choice of ρ, five out of 
sample Brier Scores are available. The signal-to-noise ratio (SNR), which is μ/σ, of these 
5 Brier Scores is calculated. Per the Rose criterion [101], SNRs above 5 are deemed to be 
“good” in the engineering literature. The SNRs are shown in the last row of Table 18; and 
at ρ of 0.82, the SNR is a maximum and satisfies the Rose criterion. Thus, overall, it is 
reasonable to take ρ = 0.82 as “optimal”.  
   
Table 18: Summary of estimated LPLMs as ρ varies 
 ρ 0.05 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.81 0.815 0.82 0.85 
In 
sample 
SBC 1710 1318 1257 1133 1036 931 878 798 761 749 737 751 723 
Variables 12 39 92 91 73 34 50 41 38 54 51 51 39 
KS (%) 78.0 89.4 94.1 95.7 95.2 91.3 95.2 95.5 95.7 96.8 96.7 96.6 95.8 
Brier 
Score 
0.115 0.062 0.031 0.023 0.025 0.038 0.026 0.026 0.025 0.017 0.018 0.019 0.022 
–2×L(·) 1610 1013 547 431 471 664 489 478 463 329 340 354 418 
 
Out of 
sample 
Brier 
Score 
SNR 
1.76 2.55 1.47 1.86 2.18 1.85 3.42 1.59 4.32 3.75 2.00 7.78 3.06 
 
The resultant LPLM is shown in Table 19. An important question is: if the LPLM 
selected variables drive O-glycosylation in Nature, would they, post-Lasso, continue to 
be statistically significant if they were put into a classical logit model to reestimate Y ?  
 
Table 19: The selected LPLM with ρ = 0.82 
Variable β Variable β Variable β Variable β 
intercept –3.7350 m6S ☼ –0.4411 p2I* –0.3424 p7T –1.0516 
m1D* 0.0982 m6V 0.5139 p2L –0.0053 p8G* ☼ –0.0074 
m1L* 1.0127 m7H 2.3444 p2P 2.6960 p8K ☼ 0.5589 
m1R* –0.1413 m7K 0.8149 p2V* ☼ 0.0130 p8N* 0.5041 
m1S –0.1913 m7L* ☼ –0.4651 p3T* 0.4597 p8Q* 0.3987 
m3A* 0.5288 m8A 0.5662 p4A* 0.9764 pos 0.3384 
m3G 1.1410 m8V –0.0763 p4E 1.3507 ASA* ☼ –0.0144 
m4N ☼ 0.1992 p1D* 0.4975 p4H –0.1231 I* –0.2885 
m4R 0.0413 p1E* ☼ –0.3194 p4I* ☼ –0.0779 Helix 1.7757 
m4V* –0.2451 p1F* 0.9501 p5H 0.1778 BH 0.3832 
m4Y* ☼ –0.0003 p1L –0.7827 p6L 1.2946 BH_strand –0.8759 
m5D 1.1952 p1S 0.1261 p6T* 1.0123 Phi angle* –0.0047 
m6E 0.0586 p1T 2.3710 p7A 1.4453 Psi angle* –0.0011 
       * / ☼ not significant at 10% in the “equivalent” classical logit model / LPM 
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Using the classical logit model, we reestimated Y with the independent variables in Table 
19. The classical logit model could not be estimated because of the problem of “quasi-
complete separation”, which makes finding the optimal maximum likelihood solution 
difficult. This problem arises when Y separates a subset of the predictors to a large enough 
degree. To resolve this problem, we used Firth’s penalized maximum likelihood method 
[101, 102]. Several predictors (23 of the 51) turn out to be statistically insignificant at the 
10% level of significance, and these are noted by asterisks in Table 19. Next, Y is 
reestimated using the LPM with the predictors in Table 19. The predictors that are 
statistically insignificant (10 of the 51), in terms of White t-values, at the 10% level of 
significance are noted in Table 19 by the sun-like symbol “☼”. The LPM also indicates 
there is no multicollinearity among the predictors, because all of the VIFs are less than 10. 
However, the DW statistic drops to 0.8, likely indicating there are missing explanatory 
variables [85].    
 
Of course, given a set of predictors, the estimated coefficients produced by the classical 
logit model, the LPM, and the LPLM are not comparable, because different optimization 
procedures are used to estimate Y. However, a philosophical question arises. Suppose, 
Nature operates along a logit surface to reveal the probability of O-glycosylation, given 
sequence and structural information in the neighborhood of the S/T site; and the Lasso has 
identified the relevant predictors. It appears to us that the selected predictors should, for 
the most part, be statistically significant, in the classical sense, when they are put into a 
classical logit model. The fact that 23 of the 51 LPLM predictors are not significant is 
troubling. 
 
The rates at which the estimated models mispredict Y as 1 when it is empirically 0 (i.e., not 
O-glycosylated) in the estimation dataset, and 0 when it is empirically 1 (i.e., O-
glycosylated), is shown in Table 20, together with the fit statistics. A 50% cutoff 
probability is used to measure the mispredictions rate. 
 
Table 20: Mispredictions rate and fit statistics for selected models  
 Mispredictions rate under a 50% cutoff probability Fit statistics 
Model 
In the set of non-O-glycosylated 
sequences (Y=0), the percentage 
of those that have estimated 
probabilities of O-glycosylation 
greater than 50% ( > 0.5) 
In the set of O-glycosylated 
sequences (Y=1), the percentage 
of those that have estimated 
probabilities of O-glycosylation 
less than or equal to 50% ( ≤
0.5) 
KS Brier Score 
Ordinary LS estimated 
LPM in Table 15 0.37 0.61 99.1% 0.009 
RR estimated LPM 
(used for estimating 
the weights for the 
WLS estimated LPM 
in Table 11) 
0.28 7.90 96.7% 0.084 
LPM in Table 11 0.28 0.61 99.2% 0.009 
LPLM with ρ = 0.82 
in Table 19 0.83 3.55 96.6% 0.019 
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As can be seen in Table 20, our WLS estimated LPM (Table 11) is performing quite well 
and does have an edge over the other models. This is not surprising. For example, the 
LPLM selects a subset of variables by setting certain coefficients to exactly 0. In our 
context, the interpretation of coefficients that are exactly zero is not easy. Coefficients of 
variables may be 0 if they are “irrelevant” and uncorrelated with the “relevant” variables. 
If many variables are irrelevant one possibility is that Nature has “wasted” certain amino 
acids by placing them in certain positions along the sequence; and another possibility is 
that they are “silent”, rather than “wasted”. In contrast, RR never sets coefficients to exactly 
0. Rather, RR exhibits optimal linear shrinkage of the coefficients [103]. In particular, 
simulation studies indicate that the performance of RR dominates those of its peers such 
as partial least squares and principal component regression [103]. If we assume that Nature 
has not “wasted” amino acids, then RR is better suited to modify coefficients because 
amino acids in certain positions may have a “small” effect that is not visible. That is, the 
“relevant” amino acids may dominate the “irrelevant” ones (until a “signal” changes that) 
in determining the three-dimensional structure of the protein, and, hence, its function. Next, 
we present an example to clarify this point. 
 
Consider the case of the psi angle. It is not a predictor in Table 11, but is a predictor in 
Table 19. Because the phi and psi angles go together, an important question is whether the 
LPM in Table 11 failed to capture it as a predictor, while the LPLM in Table 19 captured 
it. The answer is “no”; because to a significant degree the psi angle is determined by the 
amino acids and the positions they occupy. To see this, a linear regression is fit with the 
psi angle as the dependent variable and sequence information as independent variables. 
The linear regression model is chosen via two steps. In the first step, stepwise variable 
selection under 5-fold CV is done so as to minimize the CV PRESS. The minimum CV 
PRESS attained was about 4,253,609 with 106 independent variables in the specification. 
Then, in the second step, because the model is heteroscedastic, the White t-values [58] are 
used to retain only those variables that have p-values less than 10% – i.e., variable subset 
selection is done, manually, using White t-values instead of classical t-values. The selected 
model is in Table 21.  
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Table 21: Regressing psi against sequence information 
Variable β 
White’s 
|t| 
Variable β 
White’s 
|t| 
Variable β 
White’s 
|t| 
intercept 164.7095 15.76 m6T -27.7795 2.28 p4P -63.4680 6.26 
m1E -41.8628 2.97 m7E 43.9542 5.47 p5C -73.2859 4.80 
m1F 13.3555 1.67 m7K -32.2923 3.01 p5E -59.8629 6.27 
m1G -39.8688 5.61 m7L 29.8517 3.96 p5F -46.9835 3.43 
m1I 39.5770 4.07 m7V -47.2830 5.75 p5H -103.8328 6.47 
m1P -88.6389 2.43 m7Y -21.9592 1.70 p5K -46.4349 5.08 
m1S 22.2152 2.37 m8G 26.2222 2.74 p5M -55.0010 2.58 
m1V 22.1718 2.53 m8I -26.1921 1.96 p5R -49.2451 3.17 
m1W -56.8472 1.73 m8K 39.6707 3.18 p5T -26.0844 3.06 
m3C -107.3697 7.69 m8L -59.0523 7.31 p5W -92.6251 6.31 
m3H -34.3322 2.59 m8M -79.0357 3.70 p6C 45.0324 4.28 
m3I 55.7918 3.38 m8Q -48.2257 3.54 p6M -103.3734 6.33 
m3P -60.7537 6.03 m8V 20.4134 1.93 p6R 42.4221 4.59 
m3Q -91.6187 6.83 p1E 21.3198 2.71 p6S 33.0045 3.96 
m3R -78.6022 7.07 p1I 57.7033 3.69 p6W 78.9544 2.14 
m3S -58.6653 4.59 p1P 168.9937 4.72 p7M -30.9223 2.37 
m3Y -43.6250 4.75 p1T 25.9053 2.81 p7Q -74.3226 5.24 
m4A -22.2813 3.06 p2A -32.4674 2.98 p7S -27.8055 2.90 
m4D 34.2970 2.86 p2I -51.3731 6.62 p7V -25.1988 2.55 
m4F -30.2667 2.51 p2Q 22.8051 2.34 p7W -126.1256 5.32 
m4H 42.5802 2.67 p2R -73.2310 6.60 p7Y -33.3375 3.33 
m4I 52.7538 6.23 p2T -24.7715 2.04 p8C -32.8242 2.11 
m4S -17.8569 2.04 p2V 28.9007 3.16 p8G 24.3492 3.24 
m5C -61.3798 5.19 p3A -33.2607 3.75 p8K -26.5478 3.16 
m5M -50.2581 2.77 p3L -32.1617 3.65 p8Q 30.6688 2.49 
m5N -45.0953 2.62 p3Q 44.6698 2.94 p8S 47.6755 4.08 
m5Q 36.6723 4.03 p3T -34.4732 3.71 p8V 24.9615 3.24 
m5R 36.6709 4.25 p4A -22.9135 2.38 p8Y 29.0752 2.56 
m6A -51.1224 3.88 p4C -54.2233 3.33 pos -45.3919 4.67 
m6D -31.7667 2.24 p4D 35.4777 3.29 ASA -0.6246 5.84 
m6K -16.0558 2.11 p4E 53.4754 6.01  
m6L -30.2475 3.66 p4F 41.2684 3.29 
m6P -62.2979 6.04 p4G 19.1452 2.11 
m6R -22.4489 2.12 p4L -21.9163 2.72 
m6S 30.1454 3.69 p4N 31.5863 1.94 
 
The model in Table 21 has 99 variables, and an adjusted R2 of about 76%. However, its 
standardized (studentized) residuals are not normally distributed as indicated by the Q-Q 
plot in Figure 7 [104]. This is not surprising, because psi is a “circular” measure and has 
heavy tails as can be seen by its tendency to cluster (with phi) in certain (and remain sparse 
in other) regions of the X-Y plane, which can be seen in the Ramachandran plot in Figure 
8 [105]. The non-normality of the residuals indicates the need to do more work to normalize 
psi. However, as fitting a model to psi is not the focus of this paper, we did not pursue that 
goal at this time (our focus is on answering the question raised in the last paragraph). 
Nonetheless, the t-values can be viewed as approximations (e.g., SNRs) for model selection 
by viewing linear regression, in this case, as purely an optimization method. In particular, 
we held the 99 variables in Table 21 “constant” and redid 5-fold CV 50 times to study the 
variability in out of sample CV PRESS values. We did this because we noted that in the 
second step used to select the model (based on White’s t-values), the new CVPRESS tends 
to exceed the minimum CV PRESS of about 4,253,609 – the reduction of 106 variables to 
99 variables is fairly small and likely explains this movement. This variability, with its 
associated summary statistics, is shown in Figure 9 by plotting the percentage increase in 
each new CV PRESS over the minimal CV PRESS (i.e., 4,253,609). Figure 9 indicates that 
this variation is about 4.5% on average, which is not large enough to reject the assumption 
that the distribution of amino acids along the sequence plays a significant role in 
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determining structure and, hence, function. Future research can more precisely 
mathematize this role. 
 
 
Figure 7: Q-Q plot of residuals for the model in Table 21 
 
 
 
Figure 8: Ramachandran Plot 
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Figure 9: Increases in CV PRESS when the model in Table 21 is subject to 5-fold CV 50 times 
 
 
The number of times predictors are selected by the LPLM as ρ varies in Table 18 is shown 
in Table 22. In particular, ρ takes 13 values in Table 18. For each ρ, an optimal LPLM is 
selected. In all, there are 13 optimal LPLMs. All possible variables are shown in a 
rectangular format in Table 22. The positions of amino acids along the sequence is shown 
in an “integer line” format in the penultimate row of Table 22. So, for example, if we are 
at position number 3 to the right of S/T in Table 22 and go up vertically 5 “cells” we would 
arrive at the row for amino acid G; and this cell would represent the dummy variable p3G 
– that is, the dummy variable representing amino acid G in position +3. The variables 
(predictors) in the LPM of Table 11 are shaded in green in Table 22. For the 13 LPLMs, 
the frequency with which a predictor occurs in the LPLMs is noted in Table 22. For 
example, the number 12 in cell (–3, G) in Table 22 means that 12 of the 13 LPLMs had 
m3G as a predictor. Similarly, the 13 in cell (8, N) means that p8N was selected as a 
predictor by all of the 13 LPLMs; and, additionally, because this cell is shaded green, p8N 
is also a predictor in the selected LPM of Table 11. As another contrasting example, the 
predictor BH (Beta Hairpin) was only selected in 3 of the 13 LPLMs, but is in the LPM of 
Table 11. In summary, the wide variation in subsets of selected LPLM predictors, as ρ 
varies, is captured in Table 22. 
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Table 22: Frequencies of variables selected by the LPLM as ρ varies* 
S 
T 
R 
U 
C 
T 
U 
R 
A 
L 
 
V 
A 
R 
I 
A 
B 
L 
E 
BH 
Strand 12 
Strand 3 
Beta 
Hairpin 
(BH) 
3 
Beta 
Bridges  
VIII 3 
IV 2 
IIʹ 
 
II 
 
I 13 
helix 12 
asa = 0 Observation-specific dummy is not estimable in a classical logit model [71, 72] 
asa 13 
psi 13 
phi 13 
 pos 5 
 
A 
M 
I 
N 
O 
 
A 
C 
I 
D 
S 
 
as 
 
D 
U 
M 
M 
I 
E 
S 
Y 
  3  7 2  
 
 
N 
O 
T 
 
A 
P 
P 
L 
I 
C 
A 
B 
L 
E 
  
 
 
 
 
 
C 
 
E 
 
N 
 
T 
 
E 
 
R 
 
      1  
W 4     1          
V 7  11 1 12    3   
 
   
T 
       12  12   12 11  
S 3  12    6 6 4  3     
R 
    7 2 11       1  
Q 
   2 
 
      5 2  10 
P 2 3       13  3 1 1   
N 
  1 3 10    3      13 
M 
    1 4       2   
L 3 12 3 4 8  13 12 3   2 12 1  
K 1 10 1  4 1         10 
I 
  5    1  12 3 7     
H 
 12         6 12   3 
G 4     13   5   
 
  10 
F 1       13     1   
E 4  5   1  12   11    3 
D 
   12   6 11  
 
   3  
C 4   4  1         
 
A 12   2  10   4 1 13   11  
 
-8 -7 -6 -5 -4 -3 -2 -1 S/T 1 2 3 4 5 6 7 8 Position number to the left of S/T Position number to the right of S/T 
* Variables in the LPM of Table 11 are shaded in green. 
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How do fit statistics like the KS statistic and the Brier Score vary for the selected LPM? 
The KS statistic is an alternative measure to the well-known Gini coefficient ([105-107] 
and [108]). The KS statistic for the LPM in Table 11 is 99.2%; and the corresponding Brier 
Score is 0.0094 (see Figure 6). To study the out of sample variation in KS statistic and 
Brier Score, we reestimate the coefficients of the LPM in Table 15 under 5-fold CV, 100 
times. That is, the predictors of this LPM are held “constant” and only their coefficients 
are reestimated by pooling the data in 4 of the 5 randomly selected folds; and then 
calculating the KS statistic and Brier Score on the remaining fold. This exercise is done 5 
times for a random selection of 5 folds. That is, 5 LPMs are estimated by partitioning the 
5 folds into 5 sets of “training” and “validation” samples; where a training sample includes 
the data in 4 of the 5 folds, and the remaining fold is used as the validation sample. In turn, 
random selection of 5 folds is done 20 times. Thus, 100 KS statistics and Brier Scores are 
produced on sample sizes of about 400 each (the estimation sample size is 2,070).    
 
The LPM in Table 15 instead of the one in Table 11 is selected for this exercise because it 
is simpler for our purpose. In particular, the difference between the two LPMs is the 
correction for heteroscedasticity, which is only a problem impacting the standard error of 
the coefficients, not their consistency. The results of this exercise are shown in Figure 10, 
which indicates that the variation in these fit statistics is restricted to fairly narrow bands. 
Thus, there is nothing unreasonable in LPM performance. 
 
 
Figure 10: KS statistic and Brier Score out-of-sample variations for the LPM 
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Is “ASA_zero” a valid, rather than spurious, predictor in the LPM? 
ASA measures the extent to which a sequence is exposed. As mentioned previously there 
are two sequences in our data that have ASA values of 0, but are deemed to be O-
glycosylated. In our model, ASA_zero is a statistically significant variable. Because of its 
special status as an “observation specific” dummy variable, it is not estimable within the 
classical logit modeling framework [71]. Its statistical significance, and persistence during 
CV, raises the open question of whether sequences that are not exposed at all have a greater 
propensity to be O-glycosylated. Although, we do not know the answer to that, we think 
that until empirical evidence to the contrary comes up, it does not hurt keeping ASA_zero 
in the LPM. Furthermore, the good news is that dropping it from the model does not change 
any of our major conclusions. That is, in our case, dropping ASA_zero as an explanatory 
variable, simply allowed its effect to be distributed among the other coefficients without 
disrupting anything. However, we did not drop it, because it is of interest to consider (until 
evidence to the contrary) its marginal contribution toward encouraging O-glycosylation.   
 
The presence of ASA_zero in the LPM, but not ASA, raises another important question: is 
ASA_zero a spurious dummy variable in the LPM, because the fundamental variable 
underlying it, ASA, is not in the LPM? The answer is “no”. And we discuss the reason for 
this next. 
 
The ultimate assumption underlying this paper is that the amino acids and the positions 
they occupy along the sequence are the “building blocks” leading to O-glycosylation. This 
means a significant amount of the information carried by ASA should be embedded in the 
amino acids and the positions they occupy in the sequences. To test this assumption, we 
searched for a linear regression model with the natural logarithm (log) of ASA as the 
dependent variable and sequence information as independent variables. Our search 
followed the same principles that were used to model psi. We used the log transformation 
to get ASA “closer” to normality, and, as a consequence, the two observations with ASA 
values of 0 also get eliminated from the estimation dataset (because log(0) is undefined). 
ASA, like psi, has “heavy” tails. The selected model is shown in Table 23. The model has 
103 predictors and an adjusted R2 of about 80%. Its in-sample average squared error (ASE) 
is about 0.0425. The studentized residual distribution in Figure 11 show the heavy tails; 
but, a reasonable amount of symmetry is preserved. The model predicts that the two 
sequences with Uniprot Accession Numbers P02730 and P 32119, which have empirical 
ASA values of 0 (see Table 13), have predicted ASA values of about 32.5 and 24.0, 
respectively.  
 
The information content in ASA generated by the amino acids and the positions they occupy 
along the sequence can be measured by how well the regression model estimates of 
log(ASA) can discriminate between O- and non-O- glycosylated sequences (i.e., Y=1 vs. 
Y=0). The KS statistic would be a measure of this. In the estimation sample, if Y is ranked 
by estimated log(ASA), the resultant KS statistic is about 32.0%, which is a strong enough 
value to not reject the assumption that the distribution of amino acids along the sequence 
does meaningfully drive ASA. Like in the case of psi, we do 5-fold CV (holding the 103 
predictors “constant”), 20 times, to study the variability in the resultant 100 realizations of 
the out of sample ASEs and KS statistics. These variabilities, which are not unreasonable 
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relative to the baseline ASE and KS statistic, are shown in Figure 12. The baseline ASE 
and KS statistic are for the model in Table 23, which is fit on the full sample.  
  
Table 23: Regressing log(ASA) against sequence information 
Variable β 
White’s 
|t| 
Variable β 
White’s 
|t| 
Variable β 
White’s 
|t| 
intercept 3.8265 79.93 m6G 0.2437 3.04 p4A -0.1698 2.96 
m1C 0.4005 4.78 m6K 0.2509 4.17 p4C -0.4837 2.44 
m1E -0.1849 2.76 m6M -0.2652 2.11 p4D -0.4424 6.50 
m1F -0.3802 9.02 m6W 0.2150 2.77 p4F -0.2666 6.08 
m1G -0.1734 4.07 m7I -0.2036 3.95 p4G -0.5605 8.13 
m1I -0.4253 7.95 m7K 0.4807 7.38 p4H -0.2247 3.50 
m1K 0.2688 3.63 m7P 0.1391 2.64 p4I 0.3184 7.64 
m1M -0.1687 2.12 m7Q 0.3848 5.22 p4S -0.1250 2.75 
m1Q 0.4901 6.87 m7R -0.2030 2.36 p4W -0.1784 2.80 
m1S 0.1580 2.89 m7S 0.2185 3.14 p5A 0.1559 3.37 
m1V 0.0999 2.51 m7V 0.2153 4.68 p5C -0.1432 2.21 
m1Y -0.2066 3.66 m7W 0.2831 2.64 p5D -0.1959 3.46 
m3F -0.4134 7.04 m8G -0.5119 11.04 p5K 0.3154 6.66 
m3G 0.1102 2.47 m8S -0.1997 4.90 p5V 0.2375 4.07 
m3I -0.4745 6.72 m8Y 0.6461 11.36 p5W 0.3914 3.95 
m3L -0.2031 4.83 p1C 0.3582 5.47 p6A 0.1402 3.83 
m3M -0.2393 3.21 p1K 0.3864 5.90 p6E -0.2923 6.89 
m3S 0.1590 2.64 p1L 0.1875 4.96 p6H 0.1935 3.36 
m3V -0.2821 4.05 p1Q -0.1655 2.41 p6I 0.3046 4.23 
m3W -0.2581 4.16 p1V 0.1280 3.00 p6K -0.1276 1.92 
m3Y -0.1855 3.34 p2E 0.1752 3.76 p7C 0.1051 1.73 
m4C 0.4717 3.35 p2F 0.1018 1.72 p7H 0.2926 4.07 
m4D 0.3255 3.79 p2G -0.2754 4.66 p7I -0.2492 3.18 
m4F 0.3545 7.04 p2K -0.1480 2.10 p7P 0.1066 2.49 
m4K 0.1518 2.83 p2N -0.1830 2.88 p7Q -0.1690 2.20 
m4L 0.1450 3.83 p2V -0.1858 3.33 p7T 0.0952 1.96 
m4P 0.4735 8.35 p3A -0.2814 5.72 p7W -0.2539 2.93 
m4Q 0.3059 5.66 p3C 0.2717 3.90 p7Y 0.2480 3.36 
m4S 0.1391 2.63 p3D -0.2040 4.27 p8G 0.1935 3.69 
m4T -0.1328 2.2 p3H -0.2118 2.19 p8H 0.2042 3.94 
m5I -0.4287 5.15 p3I -0.1469 3.65 p8K 0.3261 7.20 
m5P 0.1189 1.72 p3K -0.4302 5.66 p8L 0.1804 2.63 
m5R -0.2278 3.95 p3L -0.2711 6.92 p8R 0.2939 5.12 
m5Y -0.3245 5.27 p3R -0.1781 2.87 pos 0.1555 2.65 
m6E 0.1342 2.47 p3Y -0.2788 2.90  
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Figure 11: Distribution of studentized residuals for the model in Table 23 
Normal fit to histogram has estimated parameters: 
μ ≈ 0.0006 and σ ≈ 1.0276 
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Figure 12: Variations in ASE and KS over 100 CV trials generated by the model in Table 23 
 
 
Is it valid to use mixed data from PTMs occurring in different parts of the cell to estimate 
the LPM? 
The PTMs occur in different parts of the cell by a very complex process involving many 
different enzymes. For example, the initial processing of the N-glycosylation occurs in the 
rough ER and the process ends in the Golgi apparatus; phosphorylation occurs in the 
cytoplasm/nucleus; and O-GlcNAc proteins are also cytosolic/nuclear. So, the question is 
whether our “control” dataset (i.e., N-glycosylated sequences) is the correct “negative 
control”? The answer is “yes”. By virtue of their differences in their mechanisms and 
cellular compartmentalization, it makes logical sense to use N-glycosylated sequences as 
the negative control for O-glycosylation. For example, in the absence of a consensus 
sequon for O-glycosylated sequences, using sequences with the S/T motif within the O-
glycosylated set of sequences makes little sense because there is no guarantee that such 
sequences will not get O-glycosylated. 
 
The LPM models a binary outcome. For example, when tossing a “fair” coin, if one wants 
to model (using the LPM, say) whether the coin will come down as “head”, then one needs 
to start with two distinct data subsets: a set of heads and a set of tails [109]. One cannot 
have entries in the set of tails (the “control”) that may also be heads. From physics, we 
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know that the outcome of the toss is exact, not probabilistic [109]. However, given the 
mathematical complexity of, and the instrumentation needed for, making this prediction 
based on the laws of physics (e.g., Newton’s laws), we use the language of probability, 
instead of physics, to estimate the outcome [110]. In particular, we say the probability of 
“head” is 50%. But, although this statement is false in theory, the methodology used is an 
important approximation that can be quite useful in practice, and for guiding experimental 
work.   
 
Similarly, our use of the complex concept called “probability” in this paper does not imply 
that we are saying there is a fundamental or intrinsic randomness in how a sequence folds 
and becomes sugar linked; rather, we are saying that given the underlying complexity of 
this process (as in the case of the coin toss), our methodology, which depends on 
probabilistic ideas, may represent a reasonable approximation (via rank-ordering) to 
facilitate predicting whether a sequence is O-glycosylated [85]. Now the way we do this, 
is by starting with “partial” or “incomplete” information. That is, we start with explanatory 
variables in the ±10 positions around the S/T site. The distribution of amino acids in this 
neighborhood is considered. And the structural information at S/T is considered. For 
example, we have not considered the distribution of amino acids further away from S/T, 
which must also carry key information. So, for example, the LPM is “unaware” of the 
existence of the signal peptide in N-glycosylated proteins that sends it to a specific part of 
the cell.  
 
So, we assumed that sequence and structural information in the neighborhood of the S/T 
site is sufficient for predicting the likelihood of O-glycosylation. To validate this 
assumption, we started with Table 9, which indicates that the proportion of O-glycosylated 
proteins having the N – ~ P – S/T sequon is tiny (1.22% of O-GlcNAc and 0.77% of O-
GalNAc proteins). Given this empirical observation, we assumed that the “signature” N – 
~ P – S/T discourages O-glycosylation – i.e., it appears to be an approximate inhibitor of 
O-glycosylation. Now, a reason that only a tiny number of sequences with the N – ~ P – 
S/T sequon are O-glycosylated may be because the remaining signature around the O-
glycosylated S/T site is quite similar to the corresponding one around the N-glycosylated 
S/T site. And, there may be some “signal” outside of our chosen ±10 neighborhood that 
may occasionally allow a protein with the N – ~ P – S/T sequon to get O-glycosylated. 
However, the LPM is not trained on data outside of the ±10 neighborhood and, thus, such 
a signal, if it were to exist, is unobservable from the LPM’s frame of reference. So, our 
selecting the N-glycosylated sequences as the negative control set is independent of cell 
“compartments”. We are simply training the LPM on the signatures around the ±10 
neighborhood of the N- and O- glycosylated sequences. Furthermore, if our assumption 
regarding the signature is unreasonable, we would have seen material deterioration in 
prediction accuracy under CV, but did not.   
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The consensus composite sequon for O-glycosylation is ~ (W–S/T–W), where “~” denotes 
the “not” operator. This means ~W – S/T – W, W – S/T – ~W, or ~W – S/T – ~W are 
necessary for O-glycosylation. The RR estimated LPM approach was instrumental in 
making this finding. The consensus sequon for phosphorylation is ~ (W–S/T/Y/H–W); 
although W–S/T/Y/H–W is not an absolute inhibitor of phosphorylation. Structural 
attributes (beta turn II, II´, helix, beta bridges, beta hairpin, and the phi angle) are 
significant predictors of O-GlcNAc glycosylation. 
 
For LPM estimation it is found that N-glycosylated sequences are good approximations to 
non-O-glycosylatable sequences; although N – ~P – S/T is not an absolute inhibitor of O-
glycosylation. The selective positioning of an amino acid along the sequence, differentiates 
the PTMs of proteins. Some N-glycosylated sequences are also phosphorylated at the S/T-
site in the N – ~P – S/T sequon. ASA values for N-glycosylated sequences are stochastically 
larger than those for O-GlcNAc glycosylated sequences.  
 
The LPM with sequence and structural data as explanatory variables yields a Kolmogorov-
Smirnov (KS) statistic value of 99%. With only sequence data, the KS statistic erodes to 
80%. With 50% as the cutoff probability for predicting O-GlcNAc glycosylation, this LPM 
mispredicts 21% of out-of-sample O-GlcNAc glycosylated sequences as not being 
glycosylated. The 95% confidence interval around this mispredictions rate is 16% to 26%. 
  
Several other studies are available for the predicting the likelihood of O-glycosylation. 
These studies have employed “machine learning” techniques, like random forests and 
factor analysis, to predict O-glycosylation [111-114]. However, this approach was not 
pursued in this paper because the focus herein is on the explanatory process driving O-
glycosylation. Thus, classical hypothesis testing is germane to the present work, and 
algorithmic modeling with its pervasive focus on prediction is not, in this paper, an end in 
itself. In this sense, Cox’s crucial comment to Breiman is echoed, which is that the “starting 
point” in this paper is not the data, but the underlying process generating it [115]. 
Furthermore, echoing Cox, again, the preference in this paper is to avoid proceeding with 
“a directly empirical black-box approach” in favor of trying to “take account of some 
underlying explanatory process” that can be simply represented by the LPM. In this 
context, the Lasso penalized logistic model was also fit to the data. However, it was found 
that the LPM is quite competitive with it, and provides a simpler mechanistic understanding 
of the O-glycosylation prediction process. 
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